_MEMBER_DEGs,_MEMBER_DMRs,_LogP_DEGs,_LogP_DMRs,GO,Description,_PATTERN_,_RANK_,GiniIndex
1,1,-2.5,-5,GO:0030036,actin cytoskeleton organization,M11,2,0
1,1,-3.4,-2.2,GO:0048872,homeostasis of number of cells,M11,2,0
1,1,-3.3,-2.2,GO:0014823,response to activity,M11,2,0
1,1,-7.4,-2.3,R-HSA-9824443,Parasitic Infection Pathways,M11,2,0
1,1,-6.2,-2.1,GO:0010562,positive regulation of phosphorus metabolic process,M11,2,0
1,1,-3.5,-4.3,hsa04666,Fc gamma R-mediated phagocytosis,M11,2,0
1,1,-4.5,-2.9,R-HSA-416476,G alpha (q) signalling events,M11,2,0
1,1,-15,-2.2,GO:0071219,cellular response to molecule of bacterial origin,M11,2,0
1,1,-2.3,-4.8,GO:0035239,tube morphogenesis,M11,2,0
1,1,-2.5,-2.9,hsa04930,Type II diabetes mellitus,M11,2,0
1,1,-2.5,-2.2,WP4341,Non genomic actions of 1 25 dihydroxyvitamin D3,M11,2,0
1,1,-2.2,-2.1,GO:0001933,negative regulation of protein phosphorylation,M11,2,0
1,1,-2.3,-3.8,hsa04148,Efferocytosis,M11,2,0
1,1,-2.7,-3.2,hsa04664,Fc epsilon RI signaling pathway,M11,2,0
1,1,-5.1,-2.1,GO:0042327,positive regulation of phosphorylation,M11,2,0
1,1,-3,-2.6,GO:0050853,B cell receptor signaling pathway,M11,2,0
1,1,-3.8,-5.6,GO:0001944,vasculature development,M11,2,0
1,1,-2.6,-3.3,hsa04933,AGE-RAGE signaling pathway in diabetic complications,M11,2,0
1,1,-3.1,-5.2,R-HSA-9006934,Signaling by Receptor Tyrosine Kinases,M11,2,0
1,1,-2.2,-2.2,GO:0070482,response to oxygen levels,M11,2,0
1,1,-3,-3.9,WP4666,Hepatitis B infection,M11,2,0
1,1,-3.9,-2.1,GO:0062207,regulation of pattern recognition receptor signaling pathway,M11,2,0
1,1,-26,-2.1,GO:0042330,taxis,M11,2,0
1,1,-6.2,-3,GO:0002263,cell activation involved in immune response,M11,2,0
1,1,-15,-2.1,GO:0002831,regulation of response to biotic stimulus,M11,2,0
1,1,-2.7,-2.6,GO:0044092,negative regulation of molecular function,M11,2,0
1,1,-2.5,-2.2,hsa05166,Human T-cell leukemia virus 1 infection,M11,2,0
1,1,-2.5,-2.6,R-HSA-9013149,RAC1 GTPase cycle,M11,2,0
1,1,-2.8,-3.7,hsa05161,Hepatitis B,M11,2,0
1,1,-2.2,-4.5,GO:0099177,regulation of trans-synaptic signaling,M11,2,0
1,1,-2,-2,hsa04151,PI3K-Akt signaling pathway,M11,2,0
1,1,-2.3,-3.8,WP4747,Netrin UNC5B signaling,M11,2,0
1,1,-6.7,-4.3,GO:0051336,regulation of hydrolase activity,M11,2,0
1,1,-4.6,-3.1,GO:0045765,regulation of angiogenesis,M11,2,0
1,1,-8.3,-6,hsa05135,Yersinia infection,M11,2,0
1,1,-9.9,-2.8,GO:1902105,regulation of leukocyte differentiation,M11,2,0
1,1,-3.9,-3.8,GO:0022604,regulation of cell morphogenesis,M11,2,0
1,1,-7.7,-3.8,GO:0006897,endocytosis,M11,2,0
1,1,-9.6,-3.8,GO:0098657,import into cell,M11,2,0
1,1,-4.9,-2.9,R-HSA-76002,"Platelet activation, signaling and aggregation",M11,2,0
1,1,-26,-2.2,GO:0006935,chemotaxis,M11,2,0
1,1,-2.1,-2.7,GO:0060322,head development,M11,2,0
1,1,-5.3,-2.7,GO:1903034,regulation of response to wounding,M11,2,0
1,1,-3.7,-4.4,GO:0001525,angiogenesis,M11,2,0
1,1,-17,-2.8,R-HSA-372790,Signaling by GPCR,M11,2,0
1,1,-3.5,-2.1,GO:0002761,regulation of myeloid leukocyte differentiation,M11,2,0
1,1,-4.5,-2.1,GO:0031401,positive regulation of protein modification process,M11,2,0
1,1,-6.3,-2.4,GO:0002366,leukocyte activation involved in immune response,M11,2,0
1,1,-4.4,-2,GO:0030099,myeloid cell differentiation,M11,2,0
1,1,-3.9,-2.7,GO:0070372,regulation of ERK1 and ERK2 cascade,M11,2,0
1,1,-8.7,-2.4,R-HSA-418594,G alpha (i) signalling events,M11,2,0
1,1,-3.4,-3.4,hsa04650,Natural killer cell mediated cytotoxicity,M11,2,0
1,1,-4.6,-3.6,hsa04662,B cell receptor signaling pathway,M11,2,0
1,1,-7.4,-2.3,R-HSA-9658195,Leishmania infection,M11,2,0
1,1,-3.3,-3.5,GO:0032940,secretion by cell,M11,2,0
1,1,-8.4,-3.2,R-HSA-1280218,Adaptive Immune System,M11,2,0
1,1,-2,-2.4,GO:0050873,brown fat cell differentiation,M11,2,0
1,1,-6.2,-2.1,GO:0045937,positive regulation of phosphate metabolic process,M11,2,0
1,1,-3.5,-2.5,GO:0060759,regulation of response to cytokine stimulus,M11,2,0
1,1,-3.1,-4.5,GO:0048514,blood vessel morphogenesis,M11,2,0
1,1,-4.2,-2.5,WP3932,Focal adhesion PI3K Akt mTOR signaling,M11,2,0
1,1,-5.5,-2,R-HSA-1474244,Extracellular matrix organization,M11,2,0
1,1,-2.2,-2.7,WP2374,Oncostatin M signaling,M11,2,0
1,1,-3.1,-2.7,GO:0001959,regulation of cytokine-mediated signaling pathway,M11,2,0
1,1,-15,-3.3,R-HSA-388396,GPCR downstream signalling,M11,2,0
1,1,-4,-5.2,GO:0001568,blood vessel development,M11,2,0
1,1,-5,-3,GO:0008277,regulation of G protein-coupled receptor signaling pathway,M11,2,0
1,1,-2.9,-2.3,GO:0032673,regulation of interleukin-4 production,M11,2,0
1,1,-3.2,-4,WP3888,VEGFA VEGFR2 signaling,M11,2,0
1,1,-3.3,-2.4,GO:0010563,negative regulation of phosphorus metabolic process,M11,2,0
1,1,-5.6,-2.3,GO:0008285,negative regulation of cell population proliferation,M11,2,0
1,1,-3.3,-2.4,GO:0045936,negative regulation of phosphate metabolic process,M11,2,0
1,1,-2.9,-2,GO:0051347,positive regulation of transferase activity,M11,2,0
1,1,-2.2,-4.5,GO:0050804,modulation of chemical synaptic transmission,M11,2,0
1,1,-2,-2.5,WP3863,T cell antigen receptor TCR pathway during Staphylococcus aureus infection,M11,2,0
1,1,-2.7,-4.3,hsa04015,Rap1 signaling pathway,M11,2,0
1,1,-3.9,-4,GO:0046903,secretion,M11,2,0
1,1,-2.5,-2,GO:0050732,negative regulation of peptidyl-tyrosine phosphorylation,M11,2,0
1,1,-3,-2.7,hsa05163,Human cytomegalovirus infection,M11,2,0
1,1,-3.5,-2,M60,PID NFAT TFPATHWAY,M11,2,0
1,1,-2.3,-3.1,WP289,Myometrial relaxation and contraction pathways,M11,2,0
1,1,-3,-3.2,GO:0023061,signal release,M11,2,0
1,1,-7.2,-3.2,GO:0010720,positive regulation of cell development,M11,2,0
1,1,-22,-2.3,GO:0060326,cell chemotaxis,M11,2,0
1,1,-3.6,-2.1,hsa04611,Platelet activation,M11,2,0
1,1,-3.5,-2.5,hsa05167,Kaposi sarcoma-associated herpesvirus infection,M11,2,0
1,1,-2.8,-4.4,M186,PID PDGFRB PATHWAY,M11,2,0
1,1,-9.2,-2.5,GO:1903706,regulation of hemopoiesis,M11,2,0
1,1,-6.4,-2.1,GO:0098609,cell-cell adhesion,M11,2,0
1,1,-13,-3.8,R-HSA-109582,Hemostasis,M11,2,0
1,1,-2.1,-2.1,WP4217,Ebola virus infection in host,M11,2,0
1,1,-3.1,-3.5,GO:0140352,export from cell,M11,2,0
1,1,-4.5,-3,GO:1901342,regulation of vasculature development,M11,2,0
1,1,-3.1,-2.7,M99,PID TXA2PATHWAY,M11,2,0
1,1,-14,-2.3,GO:0071222,cellular response to lipopolysaccharide,M11,2,0
1,1,-4.9,-2.8,R-HSA-5668599,RHO GTPases Activate NADPH Oxidases,M11,2,0
1,1,-2.8,-4.9,GO:0030029,actin filament-based process,M11,2,0
1,1,-4.5,-2.6,M252,PID IL8 CXCR1 PATHWAY,M11,2,0
1,0,-3.2,0,R-HSA-419408,Lysosphingolipid and LPA receptors,M10,1,0
1,0,-3.3,0,GO:0031343,positive regulation of cell killing,M10,1,0
0,1,0,-2.8,WP5434,Cancer pathways,M01,1,0
1,0,-8.1,0,GO:0060627,regulation of vesicle-mediated transport,M10,1,0
1,0,-2.2,0,GO:0010039,response to iron ion,M10,1,0
1,0,-2.3,0,GO:0051702,biological process involved in interaction with symbiont,M10,1,0
0,1,0,-3.4,M8,PID ENDOTHELIN PATHWAY,M01,1,0
1,0,-2.4,0,R-HSA-446728,Cell junction organization,M10,1,0
0,1,0,-2.5,GO:0072348,sulfur compound transport,M01,1,0
1,0,-2.7,0,R-HSA-9725554,Differentiation of keratinocytes in interfollicular epidermis in mammalian skin,M10,1,0
0,1,0,-2.6,GO:0003181,atrioventricular valve morphogenesis,M01,1,0
1,0,-2.2,0,hsa05130,Pathogenic Escherichia coli infection,M10,1,0
1,0,-7.4,0,R-HSA-202733,Cell surface interactions at the vascular wall,M10,1,0
1,0,-4.3,0,R-HSA-844456,The NLRP3 inflammasome,M10,1,0
1,0,-5.3,0,GO:0002888,positive regulation of myeloid leukocyte mediated immunity,M10,1,0
0,1,0,-2.9,hsa04660,T cell receptor signaling pathway,M01,1,0
1,0,-3.5,0,GO:2000833,positive regulation of steroid hormone secretion,M10,1,0
0,1,0,-2.4,GO:0048667,cell morphogenesis involved in neuron differentiation,M01,1,0
1,0,-3.1,0,GO:0000302,response to reactive oxygen species,M10,1,0
1,0,-4.7,0,GO:0051345,positive regulation of hydrolase activity,M10,1,0
1,0,-8.1,0,GO:0002718,regulation of cytokine production involved in immune response,M10,1,0
1,0,-3.1,0,WP3944,Serotonin and anxiety related events,M10,1,0
1,0,-4.1,0,GO:0031622,positive regulation of fever generation,M10,1,0
1,0,-9.2,0,GO:0002819,regulation of adaptive immune response,M10,1,0
1,0,-4,0,GO:0002532,production of molecular mediator involved in inflammatory response,M10,1,0
1,0,-7.7,0,GO:1903131,mononuclear cell differentiation,M10,1,0
1,0,-4,0,GO:1903036,positive regulation of response to wounding,M10,1,0
1,0,-4.6,0,GO:0002752,cell surface pattern recognition receptor signaling pathway,M10,1,0
1,0,-4.5,0,GO:0071677,positive regulation of mononuclear cell migration,M10,1,0
1,0,-4,0,GO:0017157,regulation of exocytosis,M10,1,0
1,0,-13,0,GO:0002274,myeloid leukocyte activation,M10,1,0
0,1,0,-2.2,M62,PID EPHB FWD PATHWAY,M01,1,0
1,0,-3.5,0,hsa05171,Coronavirus disease - COVID-19,M10,1,0
1,0,-4.1,0,GO:0071347,cellular response to interleukin-1,M10,1,0
1,0,-3.3,0,WP286,IL3 signaling,M10,1,0
1,0,-17,0,GO:0030593,neutrophil chemotaxis,M10,1,0
1,0,-2.2,0,GO:0046942,carboxylic acid transport,M10,1,0
0,1,0,-2,WP702,Metapathway biotransformation Phase I and II,M01,1,0
1,0,-2.4,0,GO:0048729,tissue morphogenesis,M10,1,0
1,0,-3.9,0,M196,PID IL23 PATHWAY,M10,1,0
1,0,-2.2,0,GO:0048714,positive regulation of oligodendrocyte differentiation,M10,1,0
1,0,-2.2,0,R-HSA-9759475,Regulation of CDH11 Expression and Function,M10,1,0
1,0,-4.4,0,WP4891,COVID 19 adverse outcome pathway,M10,1,0
1,0,-3.5,0,GO:0021782,glial cell development,M10,1,0
1,0,-5,0,GO:1900015,regulation of cytokine production involved in inflammatory response,M10,1,0
1,0,-3.2,0,GO:0035821,modulation of process of another organism,M10,1,0
1,0,-7.6,0,WP2865,IL1 and megakaryocytes in obesity,M10,1,0
1,0,-2.5,0,GO:0042326,negative regulation of phosphorylation,M10,1,0
1,0,-3.7,0,GO:1903531,negative regulation of secretion by cell,M10,1,0
0,1,0,-2.7,GO:0036344,platelet morphogenesis,M01,1,0
1,0,-2.6,0,GO:0009582,detection of abiotic stimulus,M10,1,0
1,0,-2.2,0,GO:0097696,cell surface receptor signaling pathway via STAT,M10,1,0
1,0,-5.6,0,GO:0001934,positive regulation of protein phosphorylation,M10,1,0
0,1,0,-3,M8626,SIG BCR SIGNALING PATHWAY,M01,1,0
1,0,-2.5,0,GO:0002689,negative regulation of leukocyte chemotaxis,M10,1,0
1,0,-3,0,GO:0003376,sphingosine-1-phosphate receptor signaling pathway,M10,1,0
1,0,-2.4,0,GO:0043280,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process,M10,1,0
1,0,-4.5,0,WP5158,Urotensin II mediated signaling,M10,1,0
1,0,-6.1,0,hsa04640,Hematopoietic cell lineage,M10,1,0
1,0,-4.4,0,GO:0002292,T cell differentiation involved in immune response,M10,1,0
1,0,-3.1,0,GO:0030500,regulation of bone mineralization,M10,1,0
1,0,-4.6,0,GO:0007566,embryo implantation,M10,1,0
1,0,-3,0,GO:0031663,lipopolysaccharide-mediated signaling pathway,M10,1,0
1,0,-12,0,GO:0002683,negative regulation of immune system process,M10,1,0
0,1,0,-2.5,GO:0090407,organophosphate biosynthetic process,M01,1,0
1,0,-5,0,GO:0043315,positive regulation of neutrophil degranulation,M10,1,0
0,1,0,-2.2,GO:0008630,intrinsic apoptotic signaling pathway in response to DNA damage,M01,1,0
0,1,0,-2.7,GO:0060575,intestinal epithelial cell differentiation,M01,1,0
1,0,-2.2,0,GO:0034656,nucleobase-containing small molecule catabolic process,M10,1,0
0,1,0,-2.2,hsa01524,Platinum drug resistance,M01,1,0
1,0,-6,0,GO:0007189,adenylate cyclase-activating G protein-coupled receptor signaling pathway,M10,1,0
0,1,0,-3.2,R-HSA-881907,Gastrin-CREB signalling pathway via PKC and MAPK,M01,1,0
1,0,-2.4,0,GO:0043406,positive regulation of MAP kinase activity,M10,1,0
1,0,-2.5,0,GO:1900271,regulation of long-term synaptic potentiation,M10,1,0
0,1,0,-2.1,R-HSA-74158,RNA Polymerase III Transcription,M01,1,0
1,0,-5.5,0,GO:0007200,phospholipase C-activating G protein-coupled receptor signaling pathway,M10,1,0
0,1,0,-2.2,GO:0015850,organic hydroxy compound transport,M01,1,0
1,0,-6.4,0,GO:0050832,defense response to fungus,M10,1,0
0,1,0,-2.3,hsa05211,Renal cell carcinoma,M01,1,0
1,0,-3.2,0,GO:0031650,regulation of heat generation,M10,1,0
1,0,-2,0,GO:0042633,hair cycle,M10,1,0
1,0,-3.1,0,GO:0043367,"CD4-positive, alpha-beta T cell differentiation",M10,1,0
0,1,0,-2.1,GO:0032535,regulation of cellular component size,M01,1,0
1,0,-4.5,0,GO:0002920,regulation of humoral immune response,M10,1,0
0,1,0,-2.5,GO:0003179,heart valve morphogenesis,M01,1,0
1,0,-6.7,0,GO:0038094,Fc-gamma receptor signaling pathway,M10,1,0
1,0,-7.7,0,GO:0022409,positive regulation of cell-cell adhesion,M10,1,0
1,0,-2,0,GO:0009261,ribonucleotide catabolic process,M10,1,0
1,0,-4.9,0,GO:0140105,interleukin-10-mediated signaling pathway,M10,1,0
1,0,-6.7,0,GO:0070613,regulation of protein processing,M10,1,0
1,0,-8,0,WP5115,Network map of SARS CoV 2 signaling,M10,1,0
1,0,-4.3,0,GO:0010575,positive regulation of vascular endothelial growth factor production,M10,1,0
0,1,0,-2.4,GO:0051055,negative regulation of lipid biosynthetic process,M01,1,0
1,0,-2.7,0,GO:0002693,positive regulation of cellular extravasation,M10,1,0
1,0,-3.3,0,M55,PID S1P S1P3 PATHWAY,M10,1,0
0,1,0,-2.5,WP399,Wnt signaling and pluripotency,M01,1,0
1,0,-6.5,0,GO:1903557,positive regulation of tumor necrosis factor superfamily cytokine production,M10,1,0
0,1,0,-2.4,GO:0050767,regulation of neurogenesis,M01,1,0
1,0,-22,0,GO:0071345,cellular response to cytokine stimulus,M10,1,0
1,0,-2.1,0,WP4816,TGF beta receptor signaling in skeletal dysplasias,M10,1,0
1,0,-7.1,0,GO:0042119,neutrophil activation,M10,1,0
1,0,-7.6,0,GO:0032651,regulation of interleukin-1 beta production,M10,1,0
1,0,-3,0,GO:0051770,positive regulation of nitric-oxide synthase biosynthetic process,M10,1,0
1,0,-3.4,0,GO:0050868,negative regulation of T cell activation,M10,1,0
1,0,-7.4,0,WP24,Peptide GPCRs,M10,1,0
1,0,-2.1,0,GO:0001774,microglial cell activation,M10,1,0
0,1,0,-5.4,R-HSA-9675108,Nervous system development,M01,1,0
1,0,-2.5,0,GO:0046597,negative regulation of viral entry into host cell,M10,1,0
1,0,-9.5,0,WP5055,Burn wound healing,M10,1,0
1,0,-2.4,0,GO:0016485,protein processing,M10,1,0
0,1,0,-2.3,GO:0070848,response to growth factor,M01,1,0
1,0,-6.2,0,GO:0071260,cellular response to mechanical stimulus,M10,1,0
0,1,0,-3,hsa04150,mTOR signaling pathway,M01,1,0
1,0,-9.4,0,GO:0042060,wound healing,M10,1,0
1,0,-8.5,0,GO:0030097,hemopoiesis,M10,1,0
1,0,-2.1,0,GO:0033280,response to vitamin D,M10,1,0
1,0,-2.6,0,GO:0061098,positive regulation of protein tyrosine kinase activity,M10,1,0
1,0,-2.5,0,WP4141,PI3K AKT mTOR vitamin D3 signaling,M10,1,0
1,0,-2.2,0,GO:0045444,fat cell differentiation,M10,1,0
1,0,-3,0,GO:0001706,endoderm formation,M10,1,0
0,1,0,-2.3,R-HSA-111933,Calmodulin induced events,M01,1,0
1,0,-2.2,0,GO:0046889,positive regulation of lipid biosynthetic process,M10,1,0
1,0,-3.9,0,R-HSA-216083,Integrin cell surface interactions,M10,1,0
0,1,0,-3.1,GO:0003170,heart valve development,M01,1,0
1,0,-2.5,0,GO:0030449,regulation of complement activation,M10,1,0
1,0,-5.4,0,WP5088,Prostaglandin signaling,M10,1,0
0,1,0,-2.6,R-HSA-112316,Neuronal System,M01,1,0
1,0,-3.4,0,GO:0019725,cellular homeostasis,M10,1,0
1,0,-4.1,0,GO:0043271,negative regulation of monoatomic ion transport,M10,1,0
1,0,-11,0,hsa05140,Leishmaniasis,M10,1,0
1,0,-3.9,0,GO:0071276,cellular response to cadmium ion,M10,1,0
1,0,-8.3,0,R-HSA-6805567,Keratinization,M10,1,0
1,0,-3.3,0,GO:0046632,alpha-beta T cell differentiation,M10,1,0
1,0,-2.1,0,M290,PID IL12 STAT4 PATHWAY,M10,1,0
1,0,-2,0,GO:0002712,regulation of B cell mediated immunity,M10,1,0
0,1,0,-2.8,WP5094,Orexin receptor pathway,M01,1,0
1,0,-7.2,0,GO:0002521,leukocyte differentiation,M10,1,0
0,1,0,-2.4,GO:0048813,dendrite morphogenesis,M01,1,0
0,1,0,-2.3,R-HSA-5663213,RHO GTPases Activate WASPs and WAVEs,M01,1,0
0,1,0,-5.5,M272,PID CD8 TCR DOWNSTREAM PATHWAY,M01,1,0
1,0,-2.7,0,WP4564,Neural crest cell migration during development,M10,1,0
0,1,0,-2.4,hsa04066,HIF-1 signaling pathway,M01,1,0
1,0,-17,0,R-HSA-6785807,Interleukin-4 and Interleukin-13 signaling,M10,1,0
1,0,-3.1,0,GO:0045446,endothelial cell differentiation,M10,1,0
1,0,-6.3,0,M65,PID FRA PATHWAY,M10,1,0
1,0,-6.4,0,GO:0030098,lymphocyte differentiation,M10,1,0
1,0,-7,0,GO:0002698,negative regulation of immune effector process,M10,1,0
1,0,-4.9,0,M264,PID TOLL ENDOGENOUS PATHWAY,M10,1,0
1,0,-2.1,0,R-HSA-373080,Class B/2 (Secretin family receptors),M10,1,0
1,0,-10,0,GO:0002758,innate immune response-activating signaling pathway,M10,1,0
1,0,-4.6,0,GO:0044057,regulation of system process,M10,1,0
1,0,-8.7,0,GO:0044706,multi-multicellular organism process,M10,1,0
0,1,0,-2.3,WP4255,Non small cell lung cancer,M01,1,0
1,0,-2.5,0,GO:0008217,regulation of blood pressure,M10,1,0
1,0,-3.3,0,GO:0007160,cell-matrix adhesion,M10,1,0
1,0,-8.7,0,hsa04610,Complement and coagulation cascades,M10,1,0
1,0,-7.3,0,M159,PID AMB2 NEUTROPHILS PATHWAY,M10,1,0
1,0,-4.9,0,GO:0008015,blood circulation,M10,1,0
1,0,-3,0,WP15,Selenium micronutrient network,M10,1,0
1,0,-18,0,GO:0002757,immune response-activating signaling pathway,M10,1,0
1,0,-2.6,0,GO:0032733,positive regulation of interleukin-10 production,M10,1,0
1,0,-2.6,0,GO:1901654,response to ketone,M10,1,0
1,0,-8.9,0,M5883,NABA SECRETED FACTORS,M10,1,0
0,1,0,-2.4,GO:0008286,insulin receptor signaling pathway,M01,1,0
0,1,0,-2.4,R-HSA-196854,Metabolism of vitamins and cofactors,M01,1,0
0,1,0,-2.2,GO:0016049,cell growth,M01,1,0
1,0,-4.1,0,GO:0050878,regulation of body fluid levels,M10,1,0
1,0,-2,0,GO:0006767,water-soluble vitamin metabolic process,M10,1,0
1,0,-3,0,GO:1903038,negative regulation of leukocyte cell-cell adhesion,M10,1,0
0,1,0,-2.1,GO:0120033,negative regulation of plasma membrane bounded cell projection assembly,M01,1,0
1,0,-3,0,GO:0045576,mast cell activation,M10,1,0
1,0,-2.1,0,R-HSA-5357801,Programmed Cell Death,M10,1,0
1,0,-2.9,0,GO:0007015,actin filament organization,M10,1,0
1,0,-19,0,GO:0001819,positive regulation of cytokine production,M10,1,0
1,0,-2.1,0,GO:0044319,"wound healing, spreading of cells",M10,1,0
1,0,-4.3,0,GO:2001236,regulation of extrinsic apoptotic signaling pathway,M10,1,0
1,0,-9.2,0,GO:0007188,adenylate cyclase-modulating G protein-coupled receptor signaling pathway,M10,1,0
1,0,-2.7,0,GO:0035710,"CD4-positive, alpha-beta T cell activation",M10,1,0
1,0,-3.7,0,M34,PID TCR PATHWAY,M10,1,0
0,1,0,-2.9,WP4585,Cancer immunotherapy by PD 1 blockade,M01,1,0
1,0,-2.5,0,GO:0097186,amelogenesis,M10,1,0
1,0,-4.4,0,GO:1903532,positive regulation of secretion by cell,M10,1,0
0,1,0,-2.7,WP3879,4 hydroxytamoxifen dexamethasone and retinoic acids regulation of p27 expression,M01,1,0
0,1,0,-2.7,M122,PID IL2 1PATHWAY,M01,1,0
1,0,-2.7,0,GO:0002577,regulation of antigen processing and presentation,M10,1,0
1,0,-5.7,0,GO:0043313,regulation of neutrophil degranulation,M10,1,0
0,1,0,-2.5,hsa04916,Melanogenesis,M01,1,0
1,0,-5.8,0,GO:0030162,regulation of proteolysis,M10,1,0
0,1,0,-2.2,hsa04530,Tight junction,M01,1,0
0,1,0,-2.8,GO:0001501,skeletal system development,M01,1,0
1,0,-6.6,0,hsa04621,NOD-like receptor signaling pathway,M10,1,0
0,1,0,-2.1,GO:0061448,connective tissue development,M01,1,0
1,0,-3.7,0,R-HSA-1500931,Cell-Cell communication,M10,1,0
1,0,-6.5,0,GO:0006968,cellular defense response,M10,1,0
1,0,-2.4,0,GO:0042554,superoxide anion generation,M10,1,0
0,1,0,-3.7,GO:0051056,regulation of small GTPase mediated signal transduction,M01,1,0
1,0,-12,0,GO:0032102,negative regulation of response to external stimulus,M10,1,0
1,0,-2.1,0,GO:0002707,negative regulation of lymphocyte mediated immunity,M10,1,0
1,0,-3.2,0,GO:0002443,leukocyte mediated immunity,M10,1,0
1,0,-2.3,0,GO:0045940,positive regulation of steroid metabolic process,M10,1,0
1,0,-27,0,GO:0009617,response to bacterium,M10,1,0
1,0,-3.1,0,GO:0001890,placenta development,M10,1,0
1,0,-2.6,0,WP2572,Primary focal segmental glomerulosclerosis FSGS,M10,1,0
1,0,-27,0,GO:0002764,immune response-regulating signaling pathway,M10,1,0
0,1,0,-2.7,WP1981,Thyroxine thyroid hormone production,M01,1,0
1,0,-2.9,0,WP3947,Serotonin and anxiety,M10,1,0
1,0,-2.5,0,GO:0002431,Fc receptor mediated stimulatory signaling pathway,M10,1,0
1,0,-3.8,0,GO:0045637,regulation of myeloid cell differentiation,M10,1,0
1,0,-2.1,0,hsa01523,Antifolate resistance,M10,1,0
1,0,-18,0,GO:0002768,immune response-regulating cell surface receptor signaling pathway,M10,1,0
0,1,0,-2,GO:0051668,localization within membrane,M01,1,0
1,0,-5.3,0,M210,PID IL8 CXCR2 PATHWAY,M10,1,0
1,0,-3.8,0,GO:1904407,positive regulation of nitric oxide metabolic process,M10,1,0
1,0,-7.3,0,GO:1903039,positive regulation of leukocyte cell-cell adhesion,M10,1,0
0,1,0,-2.6,WP2583,T cell receptor and co stimulatory signaling,M01,1,0
0,1,0,-3.6,hsa05170,Human immunodeficiency virus 1 infection,M01,1,0
1,0,-2.1,0,R-HSA-9764260,Regulation of Expression and Function of Type II Classical Cadherins,M10,1,0
1,0,-2.1,0,GO:0034219,carbohydrate transmembrane transport,M10,1,0
1,0,-8.5,0,M169,PID INTEGRIN2 PATHWAY,M10,1,0
1,0,-4.5,0,GO:0050730,regulation of peptidyl-tyrosine phosphorylation,M10,1,0
1,0,-9.3,0,GO:0050863,regulation of T cell activation,M10,1,0
1,0,-3,0,WP5321,Prostaglandin and leukotriene metabolism in senescence,M10,1,0
1,0,-2.3,0,GO:0046850,regulation of bone remodeling,M10,1,0
1,0,-4.2,0,GO:0002407,dendritic cell chemotaxis,M10,1,0
1,0,-4,0,GO:0045577,regulation of B cell differentiation,M10,1,0
1,0,-2.8,0,GO:0019233,sensory perception of pain,M10,1,0
1,0,-3.3,0,R-HSA-2029481,FCGR activation,M10,1,0
1,0,-2.6,0,GO:1903307,positive regulation of regulated secretory pathway,M10,1,0
1,0,-3.1,0,GO:0006873,intracellular monoatomic ion homeostasis,M10,1,0
1,0,-3.6,0,GO:0032815,negative regulation of natural killer cell activation,M10,1,0
1,0,-2.4,0,R-HSA-9705462,Inactivation of CSF3 (G-CSF) signaling,M10,1,0
1,0,-3.5,0,GO:0001547,antral ovarian follicle growth,M10,1,0
0,1,0,-3.4,hsa04910,Insulin signaling pathway,M01,1,0
1,0,-2,0,GO:0045638,negative regulation of myeloid cell differentiation,M10,1,0
1,0,-24,0,GO:0030595,leukocyte chemotaxis,M10,1,0
0,1,0,-2.3,GO:0098742,cell-cell adhesion via plasma-membrane adhesion molecules,M01,1,0
0,1,0,-2.2,hsa05225,Hepatocellular carcinoma,M01,1,0
1,0,-2.6,0,GO:0010631,epithelial cell migration,M10,1,0
1,0,-2.3,0,GO:0007259,cell surface receptor signaling pathway via JAK-STAT,M10,1,0
1,0,-2.3,0,GO:1904951,positive regulation of establishment of protein localization,M10,1,0
1,0,-3.2,0,R-HSA-5621481,C-type lectin receptors (CLRs),M10,1,0
0,1,0,-2.3,hsa05230,Central carbon metabolism in cancer,M01,1,0
1,0,-2.9,0,M7,PID FCER1 PATHWAY,M10,1,0
1,0,-2,0,WP5222,2q13 copy number variation syndrome,M10,1,0
0,1,0,-2.7,hsa04810,Regulation of actin cytoskeleton,M01,1,0
0,1,0,-2.3,WP49,IL2 signaling,M01,1,0
1,0,-6.6,0,GO:0036230,granulocyte activation,M10,1,0
1,0,-3.7,0,R-HSA-9762293,Regulation of CDH11 gene transcription,M10,1,0
0,1,0,-2,GO:0048565,digestive tract development,M01,1,0
0,1,0,-2.6,GO:0001503,ossification,M01,1,0
0,1,0,-2.2,hsa04022,cGMP-PKG signaling pathway,M01,1,0
1,0,-6.4,0,WP5272,LDL influence on CD14 and TLR4,M10,1,0
0,1,0,-2.1,hsa00980,Metabolism of xenobiotics by cytochrome P450,M01,1,0
1,0,-5.4,0,GO:0072678,T cell migration,M10,1,0
1,0,-7.9,0,GO:0002687,positive regulation of leukocyte migration,M10,1,0
0,1,0,-2.6,hsa04371,Apelin signaling pathway,M01,1,0
1,0,-3.7,0,GO:0031620,regulation of fever generation,M10,1,0
1,0,-4.5,0,R-HSA-5621480,Dectin-2 family,M10,1,0
1,0,-5,0,GO:0001550,ovarian cumulus expansion,M10,1,0
1,0,-8.3,0,R-HSA-380108,Chemokine receptors bind chemokines,M10,1,0
1,0,-4.3,0,GO:1901136,carbohydrate derivative catabolic process,M10,1,0
1,0,-3,0,GO:0007620,copulation,M10,1,0
0,1,0,-2,GO:0008654,phospholipid biosynthetic process,M01,1,0
0,1,0,-2.3,GO:0021915,neural tube development,M01,1,0
1,0,-2,0,GO:0036293,response to decreased oxygen levels,M10,1,0
1,0,-2.7,0,GO:0051769,regulation of nitric-oxide synthase biosynthetic process,M10,1,0
1,0,-2.7,0,GO:1903978,regulation of microglial cell activation,M10,1,0
0,1,0,-2.5,GO:0003171,atrioventricular valve development,M01,1,0
1,0,-5.5,0,GO:0002825,regulation of T-helper 1 type immune response,M10,1,0
1,0,-3.2,0,R-HSA-9664433,Leishmania parasite growth and survival,M10,1,0
1,0,-8.7,0,GO:0032652,regulation of interleukin-1 production,M10,1,0
1,0,-2.3,0,GO:0001541,ovarian follicle development,M10,1,0
1,0,-2.1,0,GO:0002821,positive regulation of adaptive immune response,M10,1,0
1,0,-3.7,0,GO:0090303,positive regulation of wound healing,M10,1,0
1,0,-7.2,0,hsa04668,TNF signaling pathway,M10,1,0
0,1,0,-2.2,WP2037,Prolactin signaling,M01,1,0
0,1,0,-2.5,GO:0050769,positive regulation of neurogenesis,M01,1,0
1,0,-5.9,0,GO:0031960,response to corticosteroid,M10,1,0
1,0,-4.1,0,GO:0031643,positive regulation of myelination,M10,1,0
0,1,0,-2.3,M86,PID ARF6 PATHWAY,M01,1,0
1,0,-3.3,0,hsa04915,Estrogen signaling pathway,M10,1,0
1,0,-4.2,0,WP4493,Cells and molecules involved in local acute inflammatory response,M10,1,0
0,1,0,-2.2,R-HSA-8853659,RET signaling,M01,1,0
1,0,-3.8,0,GO:0045862,positive regulation of proteolysis,M10,1,0
0,1,0,-2.5,GO:0035904,aorta development,M01,1,0
1,0,-2.3,0,GO:0046634,regulation of alpha-beta T cell activation,M10,1,0
1,0,-2.4,0,GO:0046660,female sex differentiation,M10,1,0
1,0,-2.1,0,GO:0010466,negative regulation of peptidase activity,M10,1,0
1,0,-3.2,0,GO:0060670,branching involved in labyrinthine layer morphogenesis,M10,1,0
1,0,-2.7,0,R-HSA-9664323,FCGR3A-mediated IL10 synthesis,M10,1,0
1,0,-2.1,0,R-HSA-2454202,Fc epsilon receptor (FCERI) signaling,M10,1,0
1,0,-3.5,0,GO:0045687,positive regulation of glial cell differentiation,M10,1,0
1,0,-4.6,0,GO:0080164,regulation of nitric oxide metabolic process,M10,1,0
0,1,0,-2.3,GO:0043547,positive regulation of GTPase activity,M01,1,0
1,0,-3.1,0,GO:0090594,inflammatory response to wounding,M10,1,0
1,0,-2.1,0,GO:0090505,epiboly involved in wound healing,M10,1,0
1,0,-7.5,0,GO:0006909,phagocytosis,M10,1,0
1,0,-5,0,GO:0070486,leukocyte aggregation,M10,1,0
0,1,0,-2.4,GO:0030832,regulation of actin filament length,M01,1,0
1,0,-2.4,0,GO:0090279,regulation of calcium ion import,M10,1,0
1,0,-17,0,GO:1990266,neutrophil migration,M10,1,0
1,0,-17,0,GO:0050729,positive regulation of inflammatory response,M10,1,0
1,0,-4.3,0,GO:0014015,positive regulation of gliogenesis,M10,1,0
0,1,0,-3.7,GO:0030878,thyroid gland development,M01,1,0
1,0,-15,0,GO:0051249,regulation of lymphocyte activation,M10,1,0
1,0,-7.1,0,GO:0007565,female pregnancy,M10,1,0
0,1,0,-2.9,R-HSA-418597,G alpha (z) signalling events,M01,1,0
1,0,-12,0,GO:0050867,positive regulation of cell activation,M10,1,0
1,0,-2.3,0,GO:0051346,negative regulation of hydrolase activity,M10,1,0
1,0,-2.6,0,WP4300,Extracellular vesicles in the crosstalk of cardiac cells,M10,1,0
1,0,-2.3,0,GO:0060669,embryonic placenta morphogenesis,M10,1,0
1,0,-2.5,0,GO:0034612,response to tumor necrosis factor,M10,1,0
1,0,-5.3,0,GO:0003013,circulatory system process,M10,1,0
1,0,-2.4,0,GO:0046697,decidualization,M10,1,0
1,0,-6.8,0,WP3624,Lung fibrosis,M10,1,0
1,0,-2.8,0,GO:0032653,regulation of interleukin-10 production,M10,1,0
1,0,-3.1,0,R-HSA-166058,MyD88:MAL(TIRAP) cascade initiated on plasma membrane,M10,1,0
0,1,0,-2.2,WP5470,Effect of omega 3 PUFA on Huntington 39 s disease pathways,M01,1,0
1,0,-2.1,0,WP5122,Prostaglandin and leukotriene metabolism in senescence,M10,1,0
1,0,-6.5,0,hsa05144,Malaria,M10,1,0
1,0,-4.7,0,WP4136,Fibrin complement receptor 3 signaling,M10,1,0
0,1,0,-3.2,GO:0032869,cellular response to insulin stimulus,M01,1,0
0,1,0,-2.2,R-HSA-111996,Ca-dependent events,M01,1,0
1,0,-2.7,0,R-HSA-9018678,Biosynthesis of specialized proresolving mediators (SPMs),M10,1,0
1,0,-2,0,GO:0002889,regulation of immunoglobulin mediated immune response,M10,1,0
1,0,-5.4,0,GO:0051051,negative regulation of transport,M10,1,0
1,0,-3,0,GO:0046133,pyrimidine ribonucleoside catabolic process,M10,1,0
1,0,-3.4,0,GO:0045670,regulation of osteoclast differentiation,M10,1,0
1,0,-8.4,0,hsa05323,Rheumatoid arthritis,M10,1,0
1,0,-4.5,0,GO:1903707,negative regulation of hemopoiesis,M10,1,0
1,0,-2.4,0,WP5424,Omega 6 fatty acids in senescence,M10,1,0
1,0,-13,0,GO:0071396,cellular response to lipid,M10,1,0
1,0,-5.7,0,GO:0050870,positive regulation of T cell activation,M10,1,0
0,1,0,-3.1,R-HSA-9716542,"Signaling by Rho GTPases, Miro GTPases and RHOBTB3",M01,1,0
0,1,0,-2.3,GO:0048598,embryonic morphogenesis,M01,1,0
1,0,-3.2,0,WP5171,Leukotriene metabolic pathway,M10,1,0
1,0,-5.7,0,GO:0045621,positive regulation of lymphocyte differentiation,M10,1,0
1,0,-6,0,GO:0030217,T cell differentiation,M10,1,0
0,1,0,-2.1,GO:0003002,regionalization,M01,1,0
0,1,0,-3.9,GO:0048858,cell projection morphogenesis,M01,1,0
1,0,-4.3,0,GO:0097305,response to alcohol,M10,1,0
1,0,-3.8,0,GO:0032370,positive regulation of lipid transport,M10,1,0
1,0,-5.4,0,GO:0050830,defense response to Gram-positive bacterium,M10,1,0
1,0,-5.4,0,GO:0030198,extracellular matrix organization,M10,1,0
1,0,-2.2,0,GO:0034605,cellular response to heat,M10,1,0
1,0,-4.1,0,GO:0002246,wound healing involved in inflammatory response,M10,1,0
0,1,0,-4,GO:0120039,plasma membrane bounded cell projection morphogenesis,M01,1,0
1,0,-9.6,0,R-HSA-375276,Peptide ligand-binding receptors,M10,1,0
1,0,-2.1,0,R-HSA-76005,Response to elevated platelet cytosolic Ca2+,M10,1,0
1,0,-3,0,GO:0032352,positive regulation of hormone metabolic process,M10,1,0
1,0,-2.4,0,GO:2000273,positive regulation of signaling receptor activity,M10,1,0
1,0,-18,0,GO:0002694,regulation of leukocyte activation,M10,1,0
0,1,0,-2,hsa04068,FoxO signaling pathway,M01,1,0
1,0,-2.3,0,GO:0002726,positive regulation of T cell cytokine production,M10,1,0
0,1,0,-5.9,hsa04144,Endocytosis,M01,1,0
0,1,0,-2.1,GO:0007043,cell-cell junction assembly,M01,1,0
1,0,-2.5,0,R-HSA-977606,Regulation of Complement cascade,M10,1,0
1,0,-10,0,GO:0002700,regulation of production of molecular mediator of immune response,M10,1,0
1,0,-4,0,R-HSA-114604,GPVI-mediated activation cascade,M10,1,0
1,0,-3.3,0,R-HSA-9009391,Extra-nuclear estrogen signaling,M10,1,0
1,0,-8.6,0,WP455,GPCRs class A rhodopsin like,M10,1,0
1,0,-3.5,0,GO:0001910,regulation of leukocyte mediated cytotoxicity,M10,1,0
1,0,-9.4,0,GO:0042110,T cell activation,M10,1,0
1,0,-15,0,GO:0042742,defense response to bacterium,M10,1,0
1,0,-2.9,0,R-HSA-418555,G alpha (s) signalling events,M10,1,0
1,0,-4.4,0,GO:0048165,fused antrum stage,M10,1,0
1,0,-3.8,0,GO:0051591,response to cAMP,M10,1,0
1,0,-5.8,0,GO:0050864,regulation of B cell activation,M10,1,0
0,1,0,-2.4,GO:0008064,regulation of actin polymerization or depolymerization,M01,1,0
1,0,-2.6,0,WP4961,STING pathway in Kawasaki like disease and COVID 19,M10,1,0
1,0,-3.2,0,R-HSA-9662851,Anti-inflammatory response favouring Leishmania parasite infection,M10,1,0
1,0,-11,0,GO:0050764,regulation of phagocytosis,M10,1,0
1,0,-5.1,0,GO:0038093,Fc receptor signaling pathway,M10,1,0
0,1,0,-2.6,WP4540,Hippo signaling regulation,M01,1,0
1,0,-4.5,0,GO:2000377,regulation of reactive oxygen species metabolic process,M10,1,0
1,0,-3,0,GO:0015711,organic anion transport,M10,1,0
1,0,-3.6,0,GO:0048708,astrocyte differentiation,M10,1,0
1,0,-3.9,0,GO:0045620,negative regulation of lymphocyte differentiation,M10,1,0
0,1,0,-2.3,GO:0010803,regulation of tumor necrosis factor-mediated signaling pathway,M01,1,0
1,0,-2.7,0,GO:0009581,detection of external stimulus,M10,1,0
0,1,0,-3.4,GO:0001763,morphogenesis of a branching structure,M01,1,0
1,0,-5.5,0,WP5347,IL26 signaling,M10,1,0
0,1,0,-2.2,WP4787,Osteoblast differentiation and related diseases,M01,1,0
1,0,-15,0,GO:2000147,positive regulation of cell motility,M10,1,0
1,0,-5.5,0,GO:0032930,positive regulation of superoxide anion generation,M10,1,0
0,1,0,-4.2,GO:0031175,neuron projection development,M01,1,0
1,0,-3.3,0,GO:0022605,mammalian oogenesis stage,M10,1,0
1,0,-2.5,0,GO:0050765,negative regulation of phagocytosis,M10,1,0
1,0,-5.8,0,GO:0045766,positive regulation of angiogenesis,M10,1,0
1,0,-2.9,0,GO:0070374,positive regulation of ERK1 and ERK2 cascade,M10,1,0
1,0,-2.5,0,GO:2000831,regulation of steroid hormone secretion,M10,1,0
1,0,-45,0,GO:0006954,inflammatory response,M10,1,0
1,0,-2.6,0,GO:0032303,regulation of icosanoid secretion,M10,1,0
1,0,-5.7,0,GO:0032760,positive regulation of tumor necrosis factor production,M10,1,0
1,0,-3.2,0,WP1434,Osteopontin signaling,M10,1,0
0,1,0,-2.3,M127,PID ERBB1 RECEPTOR PROXIMAL PATHWAY,M01,1,0
0,1,0,-9.4,hsa04360,Axon guidance,M01,1,0
0,1,0,-2.3,GO:0018105,peptidyl-serine phosphorylation,M01,1,0
0,1,0,-4.1,GO:0043009,chordate embryonic development,M01,1,0
1,0,-5.1,0,GO:0048661,positive regulation of smooth muscle cell proliferation,M10,1,0
1,0,-5.4,0,GO:0032695,negative regulation of interleukin-12 production,M10,1,0
1,0,-2.6,0,WP2884,NRF2 pathway,M10,1,0
1,0,-2.9,0,GO:0046686,response to cadmium ion,M10,1,0
1,0,-2,0,GO:0046330,positive regulation of JNK cascade,M10,1,0
0,1,0,-2.5,hsa04330,Notch signaling pathway,M01,1,0
0,1,0,-3.5,R-HSA-170834,Signaling by TGF-beta Receptor Complex,M01,1,0
1,0,-2.2,0,GO:0070665,positive regulation of leukocyte proliferation,M10,1,0
1,0,-3.5,0,GO:2000379,positive regulation of reactive oxygen species metabolic process,M10,1,0
1,0,-4.3,0,GO:0001562,response to protozoan,M10,1,0
1,0,-3,0,R-HSA-181438,Toll Like Receptor 2 (TLR2) Cascade,M10,1,0
1,0,-5.7,0,GO:0051092,positive regulation of NF-kappaB transcription factor activity,M10,1,0
1,0,-2.7,0,GO:0019724,B cell mediated immunity,M10,1,0
1,0,-6.7,0,GO:0141060,disruption of anatomical structure in another organism,M10,1,0
0,1,0,-2.1,GO:0003151,outflow tract morphogenesis,M01,1,0
1,0,-6.8,0,hsa04625,C-type lectin receptor signaling pathway,M10,1,0
0,1,0,-2.5,M187,PID TRKR PATHWAY,M01,1,0
1,0,-6.5,0,WP2880,Glucocorticoid receptor pathway,M10,1,0
1,0,-3.2,0,M63,PID AVB3 OPN PATHWAY,M10,1,0
1,0,-2.7,0,GO:0044060,regulation of endocrine process,M10,1,0
1,0,-2.4,0,GO:0046885,regulation of hormone biosynthetic process,M10,1,0
1,0,-9.2,0,GO:0002673,regulation of acute inflammatory response,M10,1,0
0,1,0,-2,WP2571,Polycystic kidney disease pathway,M01,1,0
0,1,0,-3.1,hsa00562,Inositol phosphate metabolism,M01,1,0
1,0,-3,0,GO:0097190,apoptotic signaling pathway,M10,1,0
0,1,0,-5,CORUM:6802,VEGFR2-S1PR5-ERK1/2-PKC-alpha complex,M01,1,0
0,1,0,-2.9,hsa05207,Chemical carcinogenesis - receptor activation,M01,1,0
1,0,-3.1,0,M276,PID FGF PATHWAY,M10,1,0
1,0,-2.2,0,GO:0048608,reproductive structure development,M10,1,0
1,0,-2.1,0,GO:0008585,female gonad development,M10,1,0
1,0,-13,0,GO:0045089,positive regulation of innate immune response,M10,1,0
1,0,-7.4,0,GO:0045619,regulation of lymphocyte differentiation,M10,1,0
1,0,-3.7,0,GO:0071248,cellular response to metal ion,M10,1,0
1,0,-15,0,GO:0002833,positive regulation of response to biotic stimulus,M10,1,0
0,1,0,-2.6,GO:0048562,embryonic organ morphogenesis,M01,1,0
1,0,-7.3,0,GO:0043068,positive regulation of programmed cell death,M10,1,0
1,0,-3.8,0,GO:0045429,positive regulation of nitric oxide biosynthetic process,M10,1,0
0,1,0,-2.4,GO:0070570,regulation of neuron projection regeneration,M01,1,0
1,0,-2.8,0,M15,PID LYSOPHOSPHOLIPID PATHWAY,M10,1,0
0,1,0,-2.8,R-HSA-9012999,RHO GTPase cycle,M01,1,0
0,1,0,-4.4,GO:0048568,embryonic organ development,M01,1,0
0,1,0,-4.8,hsa04072,Phospholipase D signaling pathway,M01,1,0
1,0,-2.4,0,R-HSA-9634638,Estrogen-dependent nuclear events downstream of ESR-membrane signaling,M10,1,0
1,0,-4.9,0,GO:1901222,regulation of non-canonical NF-kappaB signal transduction,M10,1,0
1,0,-4.4,0,GO:0002861,regulation of inflammatory response to antigenic stimulus,M10,1,0
1,0,-2.3,0,GO:0051180,vitamin transport,M10,1,0
0,1,0,-2.3,hsa04725,Cholinergic synapse,M01,1,0
0,1,0,-2.7,hsa04540,Gap junction,M01,1,0
1,0,-3.1,0,GO:0014013,regulation of gliogenesis,M10,1,0
1,0,-2.1,0,GO:0048525,negative regulation of viral process,M10,1,0
0,1,0,-2.4,R-HSA-2187338,Visual phototransduction,M01,1,0
1,0,-3.8,0,GO:1901223,negative regulation of non-canonical NF-kappaB signal transduction,M10,1,0
0,1,0,-2.4,hsa04929,GnRH secretion,M01,1,0
1,0,-4.1,0,GO:0048871,multicellular organismal-level homeostasis,M10,1,0
0,1,0,-2,GO:0048732,gland development,M01,1,0
1,0,-2.6,0,M155,PID S1P META PATHWAY,M10,1,0
0,1,0,-2.4,hsa05205,Proteoglycans in cancer,M01,1,0
1,0,-6.9,0,WP4478,LTF danger signal response pathway,M10,1,0
1,0,-3.1,0,GO:0002686,negative regulation of leukocyte migration,M10,1,0
1,0,-2.4,0,GO:0045685,regulation of glial cell differentiation,M10,1,0
1,0,-2.9,0,GO:0140895,cell surface toll-like receptor signaling pathway,M10,1,0
0,1,0,-2.1,GO:0006650,glycerophospholipid metabolic process,M01,1,0
1,0,-2.2,0,R-HSA-425407,SLC-mediated transmembrane transport,M10,1,0
1,0,-2.6,0,GO:0001912,positive regulation of leukocyte mediated cytotoxicity,M10,1,0
0,1,0,-2.4,GO:2000463,positive regulation of excitatory postsynaptic potential,M01,1,0
1,0,-3.7,0,GO:1900016,negative regulation of cytokine production involved in inflammatory response,M10,1,0
0,1,0,-2.7,GO:0007389,pattern specification process,M01,1,0
1,0,-3.7,0,GO:0030574,collagen catabolic process,M10,1,0
0,1,0,-3.1,GO:0060438,trachea development,M01,1,0
0,1,0,-3,WP481,Insulin signaling,M01,1,0
0,1,0,-3.6,hsa05235,PD-L1 expression and PD-1 checkpoint pathway in cancer,M01,1,0
1,0,-4,0,GO:0061041,regulation of wound healing,M10,1,0
1,0,-6,0,GO:0002705,positive regulation of leukocyte mediated immunity,M10,1,0
0,1,0,-2.4,hsa04720,Long-term potentiation,M01,1,0
1,0,-8.7,0,GO:0030855,epithelial cell differentiation,M10,1,0
1,0,-4.2,0,R-HSA-5602358,Diseases associated with the TLR signaling cascade,M10,1,0
1,0,-3.7,0,GO:0045123,cellular extravasation,M10,1,0
1,0,-4.4,0,M167,PID AP1 PATHWAY,M10,1,0
1,0,-4.3,0,GO:0045471,response to ethanol,M10,1,0
1,0,-3,0,GO:0002730,regulation of dendritic cell cytokine production,M10,1,0
0,1,0,-2.2,WP4172,PI3K Akt signaling,M01,1,0
1,0,-8.3,0,hsa04657,IL-17 signaling pathway,M10,1,0
1,0,-3.4,0,GO:0104004,cellular response to environmental stimulus,M10,1,0
0,1,0,-2.4,GO:0009410,response to xenobiotic stimulus,M01,1,0
1,0,-9.8,0,GO:0008544,epidermis development,M10,1,0
1,0,-2.4,0,GO:0090130,tissue migration,M10,1,0
0,1,0,-3.1,GO:0016525,negative regulation of angiogenesis,M01,1,0
0,1,0,-2.7,GO:0007272,ensheathment of neurons,M01,1,0
0,1,0,-2.7,hsa04658,Th1 and Th2 cell differentiation,M01,1,0
1,0,-2.7,0,GO:0051385,response to mineralocorticoid,M10,1,0
0,1,0,-3,WP4566,Translation inhibitors in chronically activated PDGFRA cells,M01,1,0
0,1,0,-4.2,WP5345,1p36 copy number variation syndrome,M01,1,0
0,1,0,-3.7,M269,PID RAS PATHWAY,M01,1,0
1,0,-2,0,M10,PID BCR 5PATHWAY,M10,1,0
1,0,-13,0,GO:0002699,positive regulation of immune effector process,M10,1,0
1,0,-12,0,GO:0032649,regulation of type II interferon production,M10,1,0
1,0,-2.9,0,R-HSA-180292,GAB1 signalosome,M10,1,0
1,0,-5.9,0,GO:0032677,regulation of interleukin-8 production,M10,1,0
1,0,-6.9,0,GO:0032731,positive regulation of interleukin-1 beta production,M10,1,0
0,1,0,-2.2,WP69,T cell receptor signaling,M01,1,0
1,0,-2.8,0,GO:0030003,intracellular monoatomic cation homeostasis,M10,1,0
1,0,-5,0,hsa05146,Amoebiasis,M10,1,0
1,0,-7.3,0,hsa05134,Legionellosis,M10,1,0
1,0,-5.9,0,GO:0045807,positive regulation of endocytosis,M10,1,0
1,0,-5.1,0,GO:0010959,regulation of metal ion transport,M10,1,0
1,0,-6.4,0,GO:1990868,response to chemokine,M10,1,0
1,0,-2.1,0,GO:0032647,regulation of interferon-alpha production,M10,1,0
0,1,0,-2.3,M237,PID VEGFR1 2 PATHWAY,M01,1,0
1,0,-3.4,0,GO:0035987,endodermal cell differentiation,M10,1,0
1,0,-3,0,M166,PID ATF2 PATHWAY,M10,1,0
1,0,-6.3,0,GO:0007229,integrin-mediated signaling pathway,M10,1,0
1,0,-6,0,GO:0150077,regulation of neuroinflammatory response,M10,1,0
1,0,-3.7,0,R-HSA-5686938,Regulation of TLR by endogenous ligand,M10,1,0
1,0,-11,0,GO:0006959,humoral immune response,M10,1,0
1,0,-2.2,0,WP560,TGF beta receptor signaling,M10,1,0
0,1,0,-2.3,GO:0006631,fatty acid metabolic process,M01,1,0
1,0,-5.9,0,hsa04064,NF-kappa B signaling pathway,M10,1,0
0,1,0,-2.7,GO:0030833,regulation of actin filament polymerization,M01,1,0
0,1,0,-2.9,hsa04722,Neurotrophin signaling pathway,M01,1,0
0,1,0,-2.7,WP2795,Cardiac hypertrophic response,M01,1,0
1,0,-16,0,WP5473,Cytokine cytokine receptor interaction,M10,1,0
1,0,-16,0,R-HSA-500792,GPCR ligand binding,M10,1,0
1,0,-2.5,0,M183,PID IL6 7 PATHWAY,M10,1,0
1,0,-9.9,0,GO:0002218,activation of innate immune response,M10,1,0
1,0,-2.6,0,R-HSA-2142691,Synthesis of Leukotrienes (LT) and Eoxins (EX),M10,1,0
1,0,-2,0,GO:0042542,response to hydrogen peroxide,M10,1,0
1,0,-4.8,0,GO:0031341,regulation of cell killing,M10,1,0
1,0,-9.5,0,hsa05152,Tuberculosis,M10,1,0
1,0,-3,0,GO:0060135,maternal process involved in female pregnancy,M10,1,0
1,0,-4.3,0,GO:0032692,negative regulation of interleukin-1 production,M10,1,0
1,0,-2.9,0,GO:0050731,positive regulation of peptidyl-tyrosine phosphorylation,M10,1,0
1,0,-3.2,0,WP129,Matrix metalloproteinases,M10,1,0
0,1,0,-2.3,GO:0051693,actin filament capping,M01,1,0
1,0,-2.1,0,GO:1900745,positive regulation of p38MAPK cascade,M10,1,0
1,0,-3.2,0,GO:0007320,insemination,M10,1,0
0,1,0,-2.7,WP3668,Hypothesized pathways in pathogenesis of cardiovascular disease,M01,1,0
0,1,0,-2.4,GO:0048679,regulation of axon regeneration,M01,1,0
1,0,-3.4,0,WP5390,Pancreatic cancer subtypes,M10,1,0
1,0,-25,0,GO:0031349,positive regulation of defense response,M10,1,0
1,0,-2.8,0,GO:0030889,negative regulation of B cell proliferation,M10,1,0
1,0,-3,0,GO:0090520,sphingolipid mediated signaling pathway,M10,1,0
0,1,0,-2.1,GO:0010591,regulation of lamellipodium assembly,M01,1,0
1,0,-4.7,0,GO:0002820,negative regulation of adaptive immune response,M10,1,0
1,0,-2.3,0,M115,PID REG GR PATHWAY,M10,1,0
1,0,-2.1,0,GO:0033238,regulation of amine metabolic process,M10,1,0
1,0,-3,0,R-HSA-975163,IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation,M10,1,0
1,0,-3.1,0,GO:0070542,response to fatty acid,M10,1,0
1,0,-5.1,0,GO:0051090,regulation of DNA-binding transcription factor activity,M10,1,0
0,1,0,-3.1,GO:0016358,dendrite development,M01,1,0
0,1,0,-3.2,M164,PID ERBB1 DOWNSTREAM PATHWAY,M01,1,0
1,0,-3.2,0,GO:0043123,positive regulation of canonical NF-kappaB signal transduction,M10,1,0
1,0,-4.7,0,GO:0051047,positive regulation of secretion,M10,1,0
1,0,-2.6,0,WP176,Folate metabolism,M10,1,0
1,0,-4.1,0,GO:0003018,vascular process in circulatory system,M10,1,0
1,0,-4.7,0,GO:1902106,negative regulation of leukocyte differentiation,M10,1,0
1,0,-3.4,0,GO:0032892,positive regulation of organic acid transport,M10,1,0
1,0,-6.7,0,hsa04145,Phagosome,M10,1,0
1,0,-3,0,R-HSA-166658,Complement cascade,M10,1,0
1,0,-3.1,0,GO:0007492,endoderm development,M10,1,0
1,0,-4.1,0,GO:0010721,negative regulation of cell development,M10,1,0
0,1,0,-3.1,hsa04914,Progesterone-mediated oocyte maturation,M01,1,0
1,0,-3.2,0,GO:0010001,glial cell differentiation,M10,1,0
1,0,-2.3,0,GO:1903319,positive regulation of protein maturation,M10,1,0
1,0,-6.6,0,GO:1902624,positive regulation of neutrophil migration,M10,1,0
1,0,-16,0,M5885,NABA MATRISOME ASSOCIATED,M10,1,0
1,0,-5.8,0,GO:1904018,positive regulation of vasculature development,M10,1,0
1,0,-3.5,0,GO:0090023,positive regulation of neutrophil chemotaxis,M10,1,0
1,0,-3.1,0,R-HSA-168188,Toll Like Receptor TLR6:TLR2 Cascade,M10,1,0
1,0,-2.4,0,WP395,IL4 signaling,M10,1,0
0,1,0,-2.9,WP363,Wnt signaling,M01,1,0
1,0,-2.4,0,WP5380,5q35 copy number variation,M10,1,0
1,0,-10,0,hsa04613,Neutrophil extracellular trap formation,M10,1,0
1,0,-2.5,0,GO:0060143,positive regulation of syncytium formation by plasma membrane fusion,M10,1,0
0,1,0,-2.1,WP2636,Common pathways underlying drug addiction,M01,1,0
1,0,-3,0,WP4298,Acute viral myocarditis,M10,1,0
1,0,-10,0,WP2431,Spinal cord injury,M10,1,0
1,0,-5.4,0,GO:0098543,detection of other organism,M10,1,0
0,1,0,-5.8,GO:0120035,regulation of plasma membrane bounded cell projection organization,M01,1,0
1,0,-2.6,0,GO:0070167,regulation of biomineral tissue development,M10,1,0
0,1,0,-4,GO:0048812,neuron projection morphogenesis,M01,1,0
1,0,-5.4,0,GO:0002704,negative regulation of leukocyte mediated immunity,M10,1,0
0,1,0,-2.7,WP35,G protein signaling,M01,1,0
1,0,-4.9,0,GO:0002720,positive regulation of cytokine production involved in immune response,M10,1,0
1,0,-4.9,0,WP3896,Dengue 2 interactions with complement and coagulation cascades,M10,1,0
0,1,0,-2.3,GO:0032228,"regulation of synaptic transmission, GABAergic",M01,1,0
1,0,-4,0,M5880,NABA ECM AFFILIATED,M10,1,0
0,1,0,-2.6,GO:0051962,positive regulation of nervous system development,M01,1,0
1,0,-2.1,0,GO:0007617,mating behavior,M10,1,0
1,0,-5,0,GO:0002709,regulation of T cell mediated immunity,M10,1,0
1,0,-2.9,0,GO:0030278,regulation of ossification,M10,1,0
1,0,-2,0,GO:0034614,cellular response to reactive oxygen species,M10,1,0
1,0,-2.7,0,GO:1903115,regulation of actin filament-based movement,M10,1,0
1,0,-2.9,0,GO:0050851,antigen receptor-mediated signaling pathway,M10,1,0
1,0,-9.1,0,GO:0031424,keratinization,M10,1,0
1,0,-6.9,0,GO:0002286,T cell activation involved in immune response,M10,1,0
0,1,0,-2.5,GO:0031400,negative regulation of protein modification process,M01,1,0
1,0,-16,0,GO:0030335,positive regulation of cell migration,M10,1,0
1,0,-4.4,0,GO:0010950,positive regulation of endopeptidase activity,M10,1,0
1,0,-4.1,0,M3468,NABA ECM REGULATORS,M10,1,0
1,0,-3.9,0,R-HSA-9012546,Interleukin-18 signaling,M10,1,0
1,0,-8.7,0,GO:0002675,positive regulation of acute inflammatory response,M10,1,0
1,0,-5.1,0,M124,PID CXCR4 PATHWAY,M10,1,0
1,0,-3,0,M110,PID IL1 PATHWAY,M10,1,0
1,0,-2.2,0,GO:0060142,regulation of syncytium formation by plasma membrane fusion,M10,1,0
1,0,-3.2,0,R-HSA-75205,Dissolution of Fibrin Clot,M10,1,0
1,0,-3.3,0,WP4495,IL10 anti inflammatory signaling,M10,1,0
0,1,0,-2.3,GO:0051148,negative regulation of muscle cell differentiation,M01,1,0
1,0,-2.2,0,GO:0031664,regulation of lipopolysaccharide-mediated signaling pathway,M10,1,0
1,0,-3.6,0,R-HSA-6803157,Antimicrobial peptides,M10,1,0
1,0,-2.9,0,R-HSA-1222556,ROS and RNS production in phagocytes,M10,1,0
1,0,-16,0,R-HSA-449147,Signaling by Interleukins,M10,1,0
1,0,-2.5,0,GO:0006801,superoxide metabolic process,M10,1,0
1,0,-2.4,0,GO:0002064,epithelial cell development,M10,1,0
1,0,-6.4,0,GO:1990869,cellular response to chemokine,M10,1,0
1,0,-3.3,0,R-HSA-5669034,TNFs bind their physiological receptors,M10,1,0
1,0,-19,0,GO:0019221,cytokine-mediated signaling pathway,M10,1,0
1,0,-3,0,hsa05202,Transcriptional misregulation in cancer,M10,1,0
1,0,-2.9,0,GO:0001704,formation of primary germ layer,M10,1,0
1,0,-3.1,0,GO:0007187,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger",M10,1,0
0,1,0,-2.4,WP5221,2q11 2 copy number variation syndrome,M01,1,0
1,0,-6.3,0,GO:0036336,dendritic cell migration,M10,1,0
1,0,-6,0,WP1433,Nucleotide binding oligomerization domain NOD pathway,M10,1,0
1,0,-5.6,0,GO:0002250,adaptive immune response,M10,1,0
1,0,-3.6,0,GO:0032945,negative regulation of mononuclear cell proliferation,M10,1,0
1,0,-3.6,0,WP75,Toll like receptor signaling,M10,1,0
0,1,0,-2.8,R-HSA-112315,Transmission across Chemical Synapses,M01,1,0
0,1,0,-2.1,R-HSA-3560782,Diseases associated with glycosaminoglycan metabolism,M01,1,0
1,0,-5.3,0,GO:0043269,regulation of monoatomic ion transport,M10,1,0
1,0,-3.2,0,GO:0032890,regulation of organic acid transport,M10,1,0
1,0,-2.2,0,GO:1903901,negative regulation of viral life cycle,M10,1,0
1,0,-4.2,0,GO:0006898,receptor-mediated endocytosis,M10,1,0
1,0,-11,0,GO:0009611,response to wounding,M10,1,0
1,0,-2.4,0,GO:0034381,plasma lipoprotein particle clearance,M10,1,0
0,1,0,-2.9,GO:2001222,regulation of neuron migration,M01,1,0
1,0,-2.7,0,GO:0060353,regulation of cell adhesion molecule production,M10,1,0
1,0,-4,0,R-HSA-1474228,Degradation of the extracellular matrix,M10,1,0
1,0,-2.8,0,GO:0045103,intermediate filament-based process,M10,1,0
1,0,-3.8,0,R-HSA-9031628,NGF-stimulated transcription,M10,1,0
0,1,0,-2.2,GO:0032868,response to insulin,M01,1,0
1,0,-2,0,GO:1903035,negative regulation of response to wounding,M10,1,0
1,0,-2.9,0,GO:0007611,learning or memory,M10,1,0
1,0,-3.9,0,GO:0045859,regulation of protein kinase activity,M10,1,0
0,1,0,-2.9,GO:0048538,thymus development,M01,1,0
1,0,-2.1,0,GO:0006937,regulation of muscle contraction,M10,1,0
1,0,-4.8,0,GO:0045744,negative regulation of G protein-coupled receptor signaling pathway,M10,1,0
0,1,0,-2,GO:1905475,regulation of protein localization to membrane,M01,1,0
1,0,-4.5,0,GO:0043304,regulation of mast cell degranulation,M10,1,0
1,0,-4.7,0,GO:0002548,monocyte chemotaxis,M10,1,0
1,0,-7.2,0,WP5218,Extrafollicular and follicular B cell activation by SARS CoV 2,M10,1,0
1,0,-3.6,0,M255,PID HIF1 TFPATHWAY,M10,1,0
1,0,-8.9,0,GO:0002822,regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,M10,1,0
1,0,-3.3,0,GO:0042832,defense response to protozoan,M10,1,0
0,1,0,-4.4,WP4871,Kisspeptin kisspeptin receptor system in the ovary,M01,1,0
1,0,-3.6,0,GO:2000193,positive regulation of fatty acid transport,M10,1,0
1,0,-2.6,0,GO:0003158,endothelium development,M10,1,0
1,0,-2.2,0,hsa05131,Shigellosis,M10,1,0
1,0,-5.3,0,GO:0050817,coagulation,M10,1,0
1,0,-3,0,GO:0016045,detection of bacterium,M10,1,0
0,1,0,-2.4,WP51,Regulation of actin cytoskeleton,M01,1,0
0,1,0,-4.5,GO:0006468,protein phosphorylation,M01,1,0
1,0,-2.3,0,GO:0009164,nucleoside catabolic process,M10,1,0
1,0,-2.3,0,GO:0002762,negative regulation of myeloid leukocyte differentiation,M10,1,0
1,0,-2.9,0,M54,PID IL12 2PATHWAY,M10,1,0
1,0,-18,0,GO:0097529,myeloid leukocyte migration,M10,1,0
1,0,-8,0,GO:0009620,response to fungus,M10,1,0
1,0,-3.4,0,GO:2001234,negative regulation of apoptotic signaling pathway,M10,1,0
1,0,-26,0,GO:0050900,leukocyte migration,M10,1,0
1,0,-2.1,0,GO:0060021,roof of mouth development,M10,1,0
0,1,0,-2.4,GO:0002275,myeloid cell activation involved in immune response,M01,1,0
1,0,-5.4,0,GO:0010817,regulation of hormone levels,M10,1,0
1,0,-7,0,GO:0030100,regulation of endocytosis,M10,1,0
0,1,0,-3.1,R-HSA-373752,Netrin-1 signaling,M01,1,0
0,1,0,-3,hsa05206,MicroRNAs in cancer,M01,1,0
1,0,-5.7,0,GO:0032663,regulation of interleukin-2 production,M10,1,0
1,0,-2.5,0,R-HSA-168181,Toll Like Receptor 7/8 (TLR7/8) Cascade,M10,1,0
1,0,-2.5,0,GO:0009743,response to carbohydrate,M10,1,0
1,0,-2.4,0,GO:0010954,positive regulation of protein processing,M10,1,0
1,0,-3.4,0,GO:0031623,receptor internalization,M10,1,0
0,1,0,-3.6,M108,PID NETRIN PATHWAY,M01,1,0
1,0,-2.7,0,GO:0002444,myeloid leukocyte mediated immunity,M10,1,0
1,0,-3.8,0,R-HSA-166016,Toll Like Receptor 4 (TLR4) Cascade,M10,1,0
1,0,-3.4,0,GO:0045109,intermediate filament organization,M10,1,0
1,0,-2.2,0,GO:1903019,negative regulation of glycoprotein metabolic process,M10,1,0
0,1,0,-3.9,hsa01521,EGFR tyrosine kinase inhibitor resistance,M01,1,0
1,0,-2,0,R-HSA-1592389,Activation of Matrix Metalloproteinases,M10,1,0
1,0,-2.8,0,GO:0042069,regulation of catecholamine metabolic process,M10,1,0
0,1,0,-4.9,M113,PID NFAT 3PATHWAY,M01,1,0
1,0,-4.7,0,GO:0071675,regulation of mononuclear cell migration,M10,1,0
0,1,0,-3,GO:2000181,negative regulation of blood vessel morphogenesis,M01,1,0
0,1,0,-3.1,R-HSA-1489509,DAG and IP3 signaling,M01,1,0
1,0,-2.1,0,M165,PID SYNDECAN 4 PATHWAY,M10,1,0
1,0,-18,0,GO:0045087,innate immune response,M10,1,0
1,0,-2.7,0,GO:0046883,regulation of hormone secretion,M10,1,0
1,0,-2.3,0,M33,PID GLYPICAN 1PATHWAY,M10,1,0
1,0,-5.3,0,GO:0032928,regulation of superoxide anion generation,M10,1,0
1,0,-6,0,GO:0043408,regulation of MAPK cascade,M10,1,0
1,0,-5.7,0,R-HSA-2172127,DAP12 interactions,M10,1,0
1,0,-19,0,GO:0032496,response to lipopolysaccharide,M10,1,0
1,0,-3.3,0,GO:0048660,regulation of smooth muscle cell proliferation,M10,1,0
0,1,0,-2,R-HSA-975634,Retinoid metabolism and transport,M01,1,0
1,0,-2.6,0,GO:0030203,glycosaminoglycan metabolic process,M10,1,0
1,0,-2.1,0,R-HSA-2871796,FCERI mediated MAPK activation,M10,1,0
1,0,-2.7,0,WP5146,Lung pathology of COVID 19,M10,1,0
1,0,-2.7,0,GO:0030888,regulation of B cell proliferation,M10,1,0
0,1,0,-2.5,GO:0072659,protein localization to plasma membrane,M01,1,0
1,0,-2.9,0,R-HSA-198725,Nuclear Events (kinase and transcription factor activation),M10,1,0
1,0,-4.2,0,GO:0071622,regulation of granulocyte chemotaxis,M10,1,0
0,1,0,-4.5,GO:0016310,phosphorylation,M01,1,0
1,0,-9,0,GO:0044703,multi-organism reproductive process,M10,1,0
0,1,0,-2.3,GO:0010976,positive regulation of neuron projection development,M01,1,0
1,0,-3.3,0,GO:0002544,chronic inflammatory response,M10,1,0
1,0,-9.1,0,GO:0002696,positive regulation of leukocyte activation,M10,1,0
1,0,-4.3,0,GO:0044403,biological process involved in symbiotic interaction,M10,1,0
0,1,0,-2.6,hsa04070,Phosphatidylinositol signaling system,M01,1,0
1,0,-2.5,0,GO:0042088,T-helper 1 type immune response,M10,1,0
1,0,-4.9,0,GO:0034341,response to type II interferon,M10,1,0
1,0,-13,0,hsa04061,Viral protein interaction with cytokine and cytokine receptor,M10,1,0
1,0,-2.6,0,GO:0002691,regulation of cellular extravasation,M10,1,0
0,1,0,-2.3,R-HSA-111997,CaM pathway,M01,1,0
1,0,-3,0,WP4496,Signal transduction through IL1R,M10,1,0
1,0,-2.4,0,GO:0007610,behavior,M10,1,0
0,1,0,-2,WP3915,Angiopoietin like protein 8 regulatory pathway,M01,1,0
1,0,-10,0,GO:0002685,regulation of leukocyte migration,M10,1,0
1,0,-3,0,GO:0006022,aminoglycan metabolic process,M10,1,0
1,0,-3,0,WP3527,Pre implantation embryo,M10,1,0
1,0,-9.9,0,GO:0002695,negative regulation of leukocyte activation,M10,1,0
1,0,-6,0,M11736,SA MMP CYTOKINE CONNECTION,M10,1,0
1,0,-2.1,0,GO:0030900,forebrain development,M10,1,0
1,0,-2.5,0,GO:0022411,cellular component disassembly,M10,1,0
0,1,0,-2,GO:0007422,peripheral nervous system development,M01,1,0
1,0,-4.2,0,GO:0070269,pyroptotic inflammatory response,M10,1,0
0,1,0,-2.9,GO:0018209,peptidyl-serine modification,M01,1,0
1,0,-8.1,0,GO:1902622,regulation of neutrophil migration,M10,1,0
0,1,0,-3,hsa05214,Glioma,M01,1,0
0,1,0,-3.8,GO:0009636,response to toxic substance,M01,1,0
1,0,-2.9,0,M22,PID GMCSF PATHWAY,M10,1,0
1,0,-4.8,0,GO:0043030,regulation of macrophage activation,M10,1,0
0,1,0,-5.6,GO:0031344,regulation of cell projection organization,M01,1,0
1,0,-7.8,0,GO:0009913,epidermal cell differentiation,M10,1,0
1,0,-2.4,0,GO:1903306,negative regulation of regulated secretory pathway,M10,1,0
1,0,-7.3,0,GO:0071496,cellular response to external stimulus,M10,1,0
0,1,0,-2.6,GO:0060996,dendritic spine development,M01,1,0
0,1,0,-2.3,WP428,Wnt signaling,M01,1,0
1,0,-2.1,0,hsa00052,Galactose metabolism,M10,1,0
1,0,-3,0,GO:1901741,positive regulation of myoblast fusion,M10,1,0
1,0,-8,0,GO:0002221,pattern recognition receptor signaling pathway,M10,1,0
0,1,0,-2.6,M235,PID TCR CALCIUM PATHWAY,M01,1,0
0,1,0,-2.9,GO:1990138,neuron projection extension,M01,1,0
1,0,-7.2,0,M174,PID UPA UPAR PATHWAY,M10,1,0
1,0,-2.5,0,GO:0000272,polysaccharide catabolic process,M10,1,0
1,0,-2.6,0,GO:0045124,regulation of bone resorption,M10,1,0
0,1,0,-2.6,GO:0006836,neurotransmitter transport,M01,1,0
1,0,-2.4,0,WP4538,Regulatory circuits of STAT3 signaling,M10,1,0
1,0,-2.4,0,GO:0042113,B cell activation,M10,1,0
1,0,-4.5,0,GO:0002690,positive regulation of leukocyte chemotaxis,M10,1,0
1,0,-4.7,0,GO:0022408,negative regulation of cell-cell adhesion,M10,1,0
0,1,0,-3.5,WP422,MAPK cascade,M01,1,0
1,0,-3.8,0,GO:0009725,response to hormone,M10,1,0
1,0,-8.1,0,GO:0051250,negative regulation of lymphocyte activation,M10,1,0
1,0,-22,0,GO:0002697,regulation of immune effector process,M10,1,0
0,1,0,-2.6,hsa05200,Pathways in cancer,M01,1,0
1,0,-2,0,GO:0097192,extrinsic apoptotic signaling pathway in absence of ligand,M10,1,0
0,1,0,-3.1,GO:1905048,regulation of metallopeptidase activity,M01,1,0
1,0,-4,0,WP5083,Neuroinflammation and glutamatergic signaling,M10,1,0
1,0,-5,0,GO:0046683,response to organophosphorus,M10,1,0
1,0,-2.3,0,WP530,Cytokines and inflammatory response,M10,1,0
1,0,-7.5,0,GO:1903530,regulation of secretion by cell,M10,1,0
1,0,-2.5,0,WP5356,Affected pathways in Duchenne muscular dystrophy,M10,1,0
1,0,-2.9,0,R-HSA-937072,TRAF6-mediated induction of TAK1 complex within TLR4 complex,M10,1,0
0,1,0,-2.6,GO:0015844,monoamine transport,M01,1,0
1,0,-4.5,0,WP5283,Chronic hyperglycemia impairment of neuron function,M10,1,0
1,0,-13,0,GO:0071674,mononuclear cell migration,M10,1,0
0,1,0,-3.1,WP268,Notch signaling,M01,1,0
1,0,-17,0,hsa04060,Cytokine-cytokine receptor interaction,M10,1,0
0,1,0,-2.9,R-HSA-73980,RNA Polymerase III Transcription Termination,M01,1,0
1,0,-3.4,0,GO:0097435,supramolecular fiber organization,M10,1,0
1,0,-2.8,0,GO:0051338,regulation of transferase activity,M10,1,0
1,0,-2.3,0,GO:1904645,response to amyloid-beta,M10,1,0
1,0,-2,0,WP4630,Measles virus infection,M10,1,0
1,0,-12,0,hsa04062,Chemokine signaling pathway,M10,1,0
0,1,0,-3.1,M144,PID CERAMIDE PATHWAY,M01,1,0
0,1,0,-2.9,GO:0038128,ERBB2 signaling pathway,M01,1,0
1,0,-2.5,0,GO:2001235,positive regulation of apoptotic signaling pathway,M10,1,0
1,0,-5.4,0,WP117,GPCRs other,M10,1,0
1,0,-3.6,0,GO:0043302,positive regulation of leukocyte degranulation,M10,1,0
1,0,-32,0,GO:0032103,positive regulation of response to external stimulus,M10,1,0
1,0,-11,0,WP2806,Complement system,M10,1,0
1,0,-3.4,0,GO:0070664,negative regulation of leukocyte proliferation,M10,1,0
1,0,-2.2,0,GO:0030857,negative regulation of epithelial cell differentiation,M10,1,0
0,1,0,-2.2,GO:0007616,long-term memory,M01,1,0
1,0,-5.2,0,GO:0007193,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway,M10,1,0
0,1,0,-3.1,hsa04921,Oxytocin signaling pathway,M01,1,0
1,0,-3.1,0,GO:0034383,low-density lipoprotein particle clearance,M10,1,0
1,0,-4.8,0,GO:0002437,inflammatory response to antigenic stimulus,M10,1,0
1,0,-5.2,0,R-HSA-622312,Inflammasomes,M10,1,0
1,0,-6,0,GO:0050920,regulation of chemotaxis,M10,1,0
1,0,-8.5,0,GO:0050766,positive regulation of phagocytosis,M10,1,0
0,1,0,-4.4,GO:0010975,regulation of neuron projection development,M01,1,0
0,1,0,-2.6,WP4223,Ras signaling,M01,1,0
0,1,0,-2.2,GO:0061138,morphogenesis of a branching epithelium,M01,1,0
0,1,0,-2.7,GO:0015695,organic cation transport,M01,1,0
1,0,-6.4,0,GO:0001906,cell killing,M10,1,0
1,0,-3.5,0,GO:2000401,regulation of lymphocyte migration,M10,1,0
1,0,-15,0,GO:0045088,regulation of innate immune response,M10,1,0
0,1,0,-2.4,R-HSA-9013148,CDC42 GTPase cycle,M01,1,0
1,0,-2.5,0,GO:0070373,negative regulation of ERK1 and ERK2 cascade,M10,1,0
1,0,-2.8,0,GO:0006953,acute-phase response,M10,1,0
1,0,-2.7,0,GO:0043409,negative regulation of MAPK cascade,M10,1,0
1,0,-2.8,0,GO:0002923,regulation of humoral immune response mediated by circulating immunoglobulin,M10,1,0
1,0,-3.2,0,GO:0010572,positive regulation of platelet activation,M10,1,0
1,0,-3,0,GO:0051928,positive regulation of calcium ion transport,M10,1,0
1,0,-2.1,0,WP2839,Hair follicle development organogenesis part 2 of 3,M10,1,0
1,0,-2.6,0,GO:1903522,regulation of blood circulation,M10,1,0
1,0,-2.1,0,WP2355,Corticotropin releasing hormone signaling,M10,1,0
0,1,0,-2.9,WP2637,Interleukin 1 IL 1 structural pathway,M01,1,0
1,0,-5.7,0,GO:0032757,positive regulation of interleukin-8 production,M10,1,0
1,0,-11,0,GO:0050728,negative regulation of inflammatory response,M10,1,0
1,0,-5.5,0,GO:1903305,regulation of regulated secretory pathway,M10,1,0
1,0,-3,0,GO:0002438,acute inflammatory response to antigenic stimulus,M10,1,0
1,0,-4.6,0,hsa04670,Leukocyte transendothelial migration,M10,1,0
0,1,0,-3.1,M222,PID CXCR3 PATHWAY,M01,1,0
1,0,-3.3,0,GO:2001238,positive regulation of extrinsic apoptotic signaling pathway,M10,1,0
1,0,-2.1,0,GO:1902042,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors,M10,1,0
0,1,0,-2.1,GO:0032956,regulation of actin cytoskeleton organization,M01,1,0
1,0,-5.6,0,GO:0002220,innate immune response activating cell surface receptor signaling pathway,M10,1,0
0,1,0,-3.8,WP4806,EGFR tyrosine kinase inhibitor resistance,M01,1,0
1,0,-4.5,0,GO:0048545,response to steroid hormone,M10,1,0
0,1,0,-2.2,GO:0048645,animal organ formation,M01,1,0
0,1,0,-2.5,GO:0030323,respiratory tube development,M01,1,0
1,0,-5.6,0,GO:0097191,extrinsic apoptotic signaling pathway,M10,1,0
1,0,-2.1,0,GO:0002708,positive regulation of lymphocyte mediated immunity,M10,1,0
0,1,0,-3.2,M81,PID CDC42 PATHWAY,M01,1,0
0,1,0,-3,GO:0007169,cell surface receptor protein tyrosine kinase signaling pathway,M01,1,0
1,0,-4,0,WP247,Small ligand GPCRs,M10,1,0
1,0,-2.8,0,WP474,Endochondral ossification,M10,1,0
0,1,0,-2.4,GO:0033559,unsaturated fatty acid metabolic process,M01,1,0
0,1,0,-2.1,GO:0051216,cartilage development,M01,1,0
1,0,-9.8,0,GO:0019730,antimicrobial humoral response,M10,1,0
1,0,-23,0,GO:0050865,regulation of cell activation,M10,1,0
1,0,-3,0,GO:0045861,negative regulation of proteolysis,M10,1,0
0,1,0,-2.4,M23,PID WNT NONCANONICAL PATHWAY,M01,1,0
0,1,0,-3.1,GO:0002281,macrophage activation involved in immune response,M01,1,0
1,0,-12,0,R-HSA-6809371,Formation of the cornified envelope,M10,1,0
1,0,-2.1,0,GO:0030856,regulation of epithelial cell differentiation,M10,1,0
1,0,-4.1,0,GO:0046631,alpha-beta T cell activation,M10,1,0
1,0,-7.3,0,GO:1903555,regulation of tumor necrosis factor superfamily cytokine production,M10,1,0
1,0,-3.7,0,GO:0033627,cell adhesion mediated by integrin,M10,1,0
1,0,-2.3,0,GO:0060259,regulation of feeding behavior,M10,1,0
0,1,0,-2.2,WP4549,Fragile X syndrome,M01,1,0
1,0,-2.2,0,WP5087,Pleural mesothelioma,M10,1,0
1,0,-3.7,0,GO:0042590,antigen processing and presentation of exogenous peptide antigen via MHC class I,M10,1,0
1,0,-2.6,0,WP4565,Neural crest cell migration in cancer,M10,1,0
1,0,-9,0,GO:0009612,response to mechanical stimulus,M10,1,0
0,1,0,-2.2,hsa05218,Melanoma,M01,1,0
1,0,-3.8,0,GO:0033674,positive regulation of kinase activity,M10,1,0
1,0,-6.9,0,GO:0002523,leukocyte migration involved in inflammatory response,M10,1,0
1,0,-2.4,0,R-HSA-9020702,Interleukin-1 signaling,M10,1,0
1,0,-5,0,WP558,Complement and coagulation cascades,M10,1,0
1,0,-4.1,0,GO:0010952,positive regulation of peptidase activity,M10,1,0
1,0,-4,0,GO:0060263,regulation of respiratory burst,M10,1,0
1,0,-5.5,0,GO:0052547,regulation of peptidase activity,M10,1,0
1,0,-5,0,GO:0019722,calcium-mediated signaling,M10,1,0
1,0,-2.5,0,GO:0061097,regulation of protein tyrosine kinase activity,M10,1,0
1,0,-3.5,0,GO:0007249,canonical NF-kappaB signal transduction,M10,1,0
1,0,-2.5,0,GO:0031641,regulation of myelination,M10,1,0
1,0,-4.3,0,GO:2000116,regulation of cysteine-type endopeptidase activity,M10,1,0
1,0,-2.5,0,GO:0060713,labyrinthine layer morphogenesis,M10,1,0
1,0,-8.7,0,WP3937,Microglia pathogen phagocytosis pathway,M10,1,0
0,1,0,-4.6,WP437,EGF EGFR signaling,M01,1,0
1,0,-2.1,0,WP1772,Apoptosis modulation and signaling,M10,1,0
1,0,-2.6,0,GO:0042454,ribonucleoside catabolic process,M10,1,0
1,0,-11,0,GO:0007159,leukocyte cell-cell adhesion,M10,1,0
1,0,-3.1,0,GO:0052372,modulation by symbiont of entry into host,M10,1,0
1,0,-2.7,0,hsa00500,Starch and sucrose metabolism,M10,1,0
0,1,0,-3.2,R-HSA-194315,Signaling by Rho GTPases,M01,1,0
1,0,-4.2,0,GO:0010038,response to metal ion,M10,1,0
1,0,-2.9,0,GO:0046135,pyrimidine nucleoside catabolic process,M10,1,0
1,0,-6.1,0,GO:0050670,regulation of lymphocyte proliferation,M10,1,0
1,0,-21,0,GO:0001775,cell activation,M10,1,0
0,1,0,-2.3,GO:0048588,developmental cell growth,M01,1,0
0,1,0,-5.2,hsa05231,Choline metabolism in cancer,M01,1,0
1,0,-6.4,0,GO:0043065,positive regulation of apoptotic process,M10,1,0
1,0,-5.3,0,GO:0090022,regulation of neutrophil chemotaxis,M10,1,0
1,0,-7.3,0,GO:0002706,regulation of lymphocyte mediated immunity,M10,1,0
1,0,-2.6,0,GO:0042698,ovulation cycle,M10,1,0
0,1,0,-4.4,GO:0007167,enzyme-linked receptor protein signaling pathway,M01,1,0
1,0,-2,0,GO:0033198,response to ATP,M10,1,0
1,0,-4.1,0,WP5090,Complement system in neuronal development and plasticity,M10,1,0
1,0,-4.4,0,R-HSA-446652,Interleukin-1 family signaling,M10,1,0
1,0,-4,0,R-HSA-168643,"Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways",M10,1,0
1,0,-3,0,GO:0046131,pyrimidine ribonucleoside metabolic process,M10,1,0
1,0,-3.3,0,GO:0046456,icosanoid biosynthetic process,M10,1,0
0,1,0,-2,GO:0010632,regulation of epithelial cell migration,M01,1,0
1,0,-6.8,0,GO:0022617,extracellular matrix disassembly,M10,1,0
1,0,-2.2,0,GO:0006027,glycosaminoglycan catabolic process,M10,1,0
1,0,-8.5,0,GO:0051046,regulation of secretion,M10,1,0
1,0,-3.3,0,GO:0043114,regulation of vascular permeability,M10,1,0
0,1,0,-2.2,GO:0051493,regulation of cytoskeleton organization,M01,1,0
1,0,-2.2,0,WP4494,Selective expression of chemokine receptors during T cell polarization,M10,1,0
1,0,-15,0,GO:0071216,cellular response to biotic stimulus,M10,1,0
0,1,0,-2.1,GO:0098916,anterograde trans-synaptic signaling,M01,1,0
1,0,-2.1,0,R-HSA-2142753,Arachidonic acid metabolism,M10,1,0
1,0,-2.1,0,GO:0032682,negative regulation of chemokine production,M10,1,0
1,0,-2.4,0,GO:0050801,monoatomic ion homeostasis,M10,1,0
1,0,-3.9,0,hsa05132,Salmonella infection,M10,1,0
1,0,-15,0,GO:0040017,positive regulation of locomotion,M10,1,0
1,0,-26,0,GO:0040011,locomotion,M10,1,0
0,1,0,-3,GO:1901343,negative regulation of vasculature development,M01,1,0
1,0,-2.5,0,GO:0010893,positive regulation of steroid biosynthetic process,M10,1,0
1,0,-2.3,0,R-HSA-5357769,Caspase activation via extrinsic apoptotic signalling pathway,M10,1,0
1,0,-5,0,GO:0072676,lymphocyte migration,M10,1,0
1,0,-8.9,0,GO:0043588,skin development,M10,1,0
1,0,-3.4,0,GO:0051043,regulation of membrane protein ectodomain proteolysis,M10,1,0
1,0,-2.3,0,WP5284,Cell interactions of the pancreatic cancer microenvironment,M10,1,0
1,0,-3.7,0,GO:0043903,regulation of biological process involved in symbiotic interaction,M10,1,0
0,1,0,-2.1,R-HSA-749476,RNA Polymerase III Abortive And Retractive Initiation,M01,1,0
1,0,-2.3,0,GO:0032753,positive regulation of interleukin-4 production,M10,1,0
1,0,-6,0,WP2849,Hematopoietic stem cell differentiation,M10,1,0
1,0,-7.6,0,GO:0002430,complement receptor mediated signaling pathway,M10,1,0
0,1,0,-3.2,hsa04014,Ras signaling pathway,M01,1,0
1,0,-4.7,0,GO:0045428,regulation of nitric oxide biosynthetic process,M10,1,0
0,1,0,-2.4,GO:0001676,long-chain fatty acid metabolic process,M01,1,0
1,0,-20,0,GO:0002237,response to molecule of bacterial origin,M10,1,0
1,0,-4.7,0,M28,PID IL4 2PATHWAY,M10,1,0
0,1,0,-3.1,WP536,Calcium regulation in cardiac cells,M01,1,0
0,1,0,-2.5,GO:0070231,T cell apoptotic process,M01,1,0
1,0,-3.5,0,M47,PID INTEGRIN CS PATHWAY,M10,1,0
1,0,-4.4,0,GO:0090322,regulation of superoxide metabolic process,M10,1,0
0,1,0,-2.3,GO:0030947,regulation of vascular endothelial growth factor receptor signaling pathway,M01,1,0
1,0,-3.2,0,hsa04620,Toll-like receptor signaling pathway,M10,1,0
1,0,-2.7,0,hsa05164,Influenza A,M10,1,0
1,0,-3.2,0,GO:0043301,negative regulation of leukocyte degranulation,M10,1,0
1,0,-5.1,0,GO:0014002,astrocyte development,M10,1,0
1,0,-22,0,GO:0050778,positive regulation of immune response,M10,1,0
1,0,-2.8,0,GO:0042053,regulation of dopamine metabolic process,M10,1,0
1,0,-19,0,GO:0045321,leukocyte activation,M10,1,0
1,0,-11,0,GO:0050866,negative regulation of cell activation,M10,1,0
1,0,-12,0,GO:0046649,lymphocyte activation,M10,1,0
1,0,-4.5,0,GO:0042129,regulation of T cell proliferation,M10,1,0
1,0,-5.7,0,GO:0007204,positive regulation of cytosolic calcium ion concentration,M10,1,0
1,0,-2.7,0,GO:0051235,maintenance of location,M10,1,0
1,0,-2.3,0,GO:0051952,regulation of amine transport,M10,1,0
0,1,0,-3.8,WP2261,Glioblastoma signaling,M01,1,0
0,1,0,-2.5,GO:0043254,regulation of protein-containing complex assembly,M01,1,0
1,0,-6.3,0,WP5485,Post COVID neuroinflammation,M10,1,0
1,0,-2.1,0,M257,PID EPHRINB REV PATHWAY,M10,1,0
1,0,-6.3,0,GO:0045730,respiratory burst,M10,1,0
1,0,-2.7,0,R-HSA-9734767,Developmental Cell Lineages,M10,1,0
1,0,-14,0,hsa04380,Osteoclast differentiation,M10,1,0
1,0,-2.1,0,GO:0043370,"regulation of CD4-positive, alpha-beta T cell differentiation",M10,1,0
1,0,-4.7,0,R-HSA-168898,Toll-like Receptor Cascades,M10,1,0
1,0,-15,0,R-HSA-198933,Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell,M10,1,0
1,0,-6.8,0,GO:0141061,disruption of cell in another organism,M10,1,0
0,1,0,-3.8,GO:0060439,trachea morphogenesis,M01,1,0
1,0,-7,0,GO:0002688,regulation of leukocyte chemotaxis,M10,1,0
1,0,-2.1,0,GO:0009895,negative regulation of catabolic process,M10,1,0
1,0,-3.1,0,GO:0071346,cellular response to type II interferon,M10,1,0
1,0,-3.2,0,GO:0045596,negative regulation of cell differentiation,M10,1,0
1,0,-2,0,GO:0042303,molting cycle,M10,1,0
1,0,-2.4,0,GO:0051701,biological process involved in interaction with host,M10,1,0
1,0,-3.2,0,GO:0098771,inorganic ion homeostasis,M10,1,0
1,0,-4.9,0,GO:0002922,positive regulation of humoral immune response,M10,1,0
1,0,-2.9,0,GO:0071417,cellular response to organonitrogen compound,M10,1,0
1,0,-3.7,0,hsa05321,Inflammatory bowel disease,M10,1,0
1,0,-2.1,0,GO:0034394,protein localization to cell surface,M10,1,0
1,0,-2,0,GO:0007420,brain development,M10,1,0
1,0,-2.6,0,R-HSA-1236975,Antigen processing-Cross presentation,M10,1,0
1,0,-2,0,GO:0019058,viral life cycle,M10,1,0
1,0,-10,0,GO:0030216,keratinocyte differentiation,M10,1,0
1,0,-2.7,0,hsa05031,Amphetamine addiction,M10,1,0
1,0,-8.5,0,GO:0002886,regulation of myeloid leukocyte mediated immunity,M10,1,0
1,0,-2.1,0,GO:0050678,regulation of epithelial cell proliferation,M10,1,0
1,0,-2.1,0,GO:0007369,gastrulation,M10,1,0
1,0,-11,0,GO:0002252,immune effector process,M10,1,0
1,0,-4.7,0,GO:0050921,positive regulation of chemotaxis,M10,1,0
1,0,-2.3,0,M88,PID CD8 TCR PATHWAY,M10,1,0
1,0,-5.3,0,GO:0043062,extracellular structure organization,M10,1,0
1,0,-2.1,0,GO:0006940,regulation of smooth muscle contraction,M10,1,0
1,0,-2.1,0,GO:0002824,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,M10,1,0
1,0,-6.5,0,GO:1903317,regulation of protein maturation,M10,1,0
0,1,0,-2.2,GO:0030835,negative regulation of actin filament depolymerization,M01,1,0
0,1,0,-2.2,hsa05223,Non-small cell lung cancer,M01,1,0
0,1,0,-2.7,GO:0099536,synaptic signaling,M01,1,0
0,1,0,-2.2,GO:0034330,cell junction organization,M01,1,0
1,0,-6.5,0,GO:1903708,positive regulation of hemopoiesis,M10,1,0
1,0,-6,0,GO:0032729,positive regulation of type II interferon production,M10,1,0
1,0,-2.3,0,GO:0002449,lymphocyte mediated immunity,M10,1,0
0,1,0,-2.2,GO:0006690,icosanoid metabolic process,M01,1,0
0,1,0,-2.7,GO:0034329,cell junction assembly,M01,1,0
1,0,-18,0,GO:0071621,granulocyte chemotaxis,M10,1,0
1,0,-2.5,0,GO:0031589,cell-substrate adhesion,M10,1,0
1,0,-4.5,0,GO:0051091,positive regulation of DNA-binding transcription factor activity,M10,1,0
1,0,-18,0,GO:0097530,granulocyte migration,M10,1,0
0,1,0,-2.4,GO:0033032,regulation of myeloid cell apoptotic process,M01,1,0
1,0,-2.4,0,GO:0032368,regulation of lipid transport,M10,1,0
1,0,-2.9,0,GO:0034121,regulation of toll-like receptor signaling pathway,M10,1,0
0,1,0,-5.4,GO:0043087,regulation of GTPase activity,M01,1,0
0,1,0,-2.4,WP5365,4p16 3 copy number variation,M01,1,0
1,0,-8,0,GO:0050777,negative regulation of immune response,M10,1,0
0,1,0,-3,GO:0031346,positive regulation of cell projection organization,M01,1,0
0,1,0,-2.1,hsa05100,Bacterial invasion of epithelial cells,M01,1,0
1,0,-2,0,GO:0046545,development of primary female sexual characteristics,M10,1,0
0,1,0,-5.1,R-HSA-422475,Axon guidance,M01,1,0
1,0,-2.8,0,GO:0032350,regulation of hormone metabolic process,M10,1,0
1,0,-2.1,0,R-HSA-9674555,Signaling by CSF3 (G-CSF),M10,1,0
1,0,-5.7,0,GO:0002285,lymphocyte activation involved in immune response,M10,1,0
1,0,-3.4,0,GO:0022602,ovulation cycle process,M10,1,0
1,0,-4.6,0,GO:0045860,positive regulation of protein kinase activity,M10,1,0
1,0,-2.3,0,GO:1901699,cellular response to nitrogen compound,M10,1,0
1,0,-5.1,0,GO:0032755,positive regulation of interleukin-6 production,M10,1,0
1,0,-6.5,0,GO:1902107,positive regulation of leukocyte differentiation,M10,1,0
1,0,-5.2,0,GO:2001233,regulation of apoptotic signaling pathway,M10,1,0
1,0,-4.7,0,WP4329,miRNA role in immune response in sepsis,M10,1,0
1,0,-10,0,GO:0022407,regulation of cell-cell adhesion,M10,1,0
0,1,0,-2.9,GO:0060425,lung morphogenesis,M01,1,0
1,0,-3.5,0,GO:0002887,negative regulation of myeloid leukocyte mediated immunity,M10,1,0
0,1,0,-3,GO:0051016,barbed-end actin filament capping,M01,1,0
0,1,0,-2.1,WP4148,Splicing factor NOVA regulated synaptic proteins,M01,1,0
1,0,-4.2,0,WP4462,Platelet mediated interactions with vascular and circulating cells,M10,1,0
1,0,-2.7,0,M18,PID INTEGRIN1 PATHWAY,M10,1,0
1,0,-2.7,0,GO:0032305,positive regulation of icosanoid secretion,M10,1,0
1,0,-23,0,GO:0050727,regulation of inflammatory response,M10,1,0
1,0,-2.5,0,R-HSA-140875,Common Pathway of Fibrin Clot Formation,M10,1,0
1,0,-2.1,0,GO:0090504,epiboly,M10,1,0
1,0,-6.1,0,GO:0070663,regulation of leukocyte proliferation,M10,1,0
1,0,-5.5,0,hsa05418,Fluid shear stress and atherosclerosis,M10,1,0
1,0,-7,0,GO:0032689,negative regulation of type II interferon production,M10,1,0
1,0,-3.2,0,GO:0008283,cell population proliferation,M10,1,0
1,0,-6,0,GO:0032944,regulation of mononuclear cell proliferation,M10,1,0
0,1,0,-5.9,GO:0000902,cell morphogenesis,M01,1,0
1,0,-6.8,0,GO:0031640,killing of cells of another organism,M10,1,0
0,1,0,-2.5,R-HSA-2173795,Downregulation of SMAD2/3:SMAD4 transcriptional activity,M01,1,0
1,0,-3.2,0,GO:0043549,regulation of kinase activity,M10,1,0
0,1,0,-2,M12,PID RHOA PATHWAY,M01,1,0
1,0,-3.5,0,GO:2001056,positive regulation of cysteine-type endopeptidase activity,M10,1,0
1,0,-4.4,0,GO:0002526,acute inflammatory response,M10,1,0
1,0,-2.6,0,GO:0009914,hormone transport,M10,1,0
0,1,0,-3.5,hsa04370,VEGF signaling pathway,M01,1,0
1,0,-3.5,0,GO:0002224,toll-like receptor signaling pathway,M10,1,0
0,1,0,-3.5,hsa04926,Relaxin signaling pathway,M01,1,0
1,0,-4.5,0,GO:0002460,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,M10,1,0
1,0,-6,0,GO:0052548,regulation of endopeptidase activity,M10,1,0
1,0,-5,0,GO:0097242,amyloid-beta clearance,M10,1,0
1,0,-3.5,0,GO:1901623,regulation of lymphocyte chemotaxis,M10,1,0
0,1,0,-3.1,hsa04931,Insulin resistance,M01,1,0
1,0,-6.6,0,WP2840,Hair follicle development cytodifferentiation stage 3 of 3,M10,1,0
0,1,0,-2.1,GO:0007268,chemical synaptic transmission,M01,1,0
1,0,-12,0,WP2877,Vitamin D receptor pathway,M10,1,0
1,0,-2.4,0,GO:0034114,regulation of heterotypic cell-cell adhesion,M10,1,0
1,0,-3.3,0,GO:0150076,neuroinflammatory response,M10,1,0
1,0,-2.9,0,GO:0043281,regulation of cysteine-type endopeptidase activity involved in apoptotic process,M10,1,0
1,0,-3.4,0,GO:0050890,cognition,M10,1,0
1,0,-6.2,0,GO:0032732,positive regulation of interleukin-1 production,M10,1,0
1,0,-6.9,0,GO:0051251,positive regulation of lymphocyte activation,M10,1,0
1,0,-2.7,0,GO:0043270,positive regulation of monoatomic ion transport,M10,1,0
0,1,0,-2.4,R-HSA-112314,Neurotransmitter receptors and postsynaptic signal transmission,M01,1,0
1,0,-10,0,WP3929,Chemokine signaling,M10,1,0
1,0,-2.5,0,GO:0090132,epithelium migration,M10,1,0
0,1,0,-2.3,GO:0034101,erythrocyte homeostasis,M01,1,0
1,0,-2.8,0,GO:0045104,intermediate filament cytoskeleton organization,M10,1,0
1,0,-4.4,0,GO:0043032,positive regulation of macrophage activation,M10,1,0
1,0,-5.7,0,GO:0032655,regulation of interleukin-12 production,M10,1,0
0,1,0,-2.2,R-HSA-9659379,Sensory processing of sound,M01,1,0
0,1,0,-2,GO:0006644,phospholipid metabolic process,M01,1,0
0,1,0,-2.2,M5884,NABA CORE MATRISOME,M01,1,0
1,0,-5.3,0,GO:0043410,positive regulation of MAPK cascade,M10,1,0
1,0,-3.9,0,GO:1905954,positive regulation of lipid localization,M10,1,0
1,0,-14,0,R-HSA-6783783,Interleukin-10 signaling,M10,1,0
1,0,-2.6,0,GO:0051926,negative regulation of calcium ion transport,M10,1,0
1,0,-2.2,0,GO:0061458,reproductive system development,M10,1,0
1,0,-7.5,0,R-HSA-9660826,Purinergic signaling in leishmaniasis infection,M10,1,0
1,0,-4.4,0,GO:0045582,positive regulation of T cell differentiation,M10,1,0
1,0,-5,0,GO:0002724,regulation of T cell cytokine production,M10,1,0
0,1,0,-2.6,GO:0030324,lung development,M01,1,0
1,0,-6.6,0,GO:0002702,positive regulation of production of molecular mediator of immune response,M10,1,0
1,0,-4.1,0,WP3877,MYD88 distinct input output pathway,M10,1,0
0,1,0,-2.2,GO:0060541,respiratory system development,M01,1,0
0,1,0,-2.5,GO:0060840,artery development,M01,1,0
1,0,-3.8,0,GO:0061900,glial cell activation,M10,1,0
1,0,-3.2,0,hsa04010,MAPK signaling pathway,M10,1,0
1,0,-2.2,0,R-HSA-418346,Platelet homeostasis,M10,1,0
1,0,-9.3,0,GO:0031348,negative regulation of defense response,M10,1,0
1,0,-3,0,GO:2000191,regulation of fatty acid transport,M10,1,0
1,0,-3.5,0,GO:0007162,negative regulation of cell adhesion,M10,1,0
0,1,0,-3.7,hsa04071,Sphingolipid signaling pathway,M01,1,0
1,0,-5,0,hsa04080,Neuroactive ligand-receptor interaction,M10,1,0
1,0,-2.2,0,WP4721,Eicosanoid metabolism via lipooxygenases LOX,M10,1,0
0,1,0,-3.4,WP4877,Host pathogen interaction of human coronaviruses MAPK signaling,M01,1,0
1,0,-3.7,0,GO:0045580,regulation of T cell differentiation,M10,1,0
1,0,-4.7,0,GO:0098581,detection of external biotic stimulus,M10,1,0
1,0,-2.6,0,WP5198,Inflammatory bowel disease signaling,M10,1,0
0,1,0,-3.3,GO:0090630,activation of GTPase activity,M01,1,0
1,0,-4.6,0,GO:0014074,response to purine-containing compound,M10,1,0
1,0,-3.1,0,WP5113,Antiviral and anti inflammatory effects of Nrf2 on SARS CoV 2 pathway,M10,1,0
1,0,-2.4,0,GO:0090280,positive regulation of calcium ion import,M10,1,0
0,1,0,-2.2,hsa05220,Chronic myeloid leukemia,M01,1,0
1,0,-3.6,0,GO:0060536,cartilage morphogenesis,M10,1,0
1,0,-3.6,0,GO:1901224,positive regulation of non-canonical NF-kappaB signal transduction,M10,1,0
1,0,-4.3,0,GO:0032722,positive regulation of chemokine production,M10,1,0
1,0,-2.2,0,GO:0010951,negative regulation of endopeptidase activity,M10,1,0
1,0,-3.5,0,GO:0002701,negative regulation of production of molecular mediator of immune response,M10,1,0
1,0,-2.2,0,GO:0015849,organic acid transport,M10,1,0
1,0,-4.1,0,GO:0010755,regulation of plasminogen activation,M10,1,0
1,0,-2.1,0,WP4304,Oligodendrocyte specification and differentiation leading to myelin components for CNS,M10,1,0
1,0,-10,0,GO:0061844,antimicrobial humoral immune response mediated by antimicrobial peptide,M10,1,0
1,0,-2.9,0,GO:0150079,negative regulation of neuroinflammatory response,M10,1,0
0,1,0,-2.9,GO:0099537,trans-synaptic signaling,M01,1,0
1,0,-2.6,0,GO:2000403,positive regulation of lymphocyte migration,M10,1,0
1,0,-2.1,0,GO:0050792,regulation of viral process,M10,1,0
1,0,-14,0,R-HSA-1280215,Cytokine Signaling in Immune system,M10,1,0
1,0,-3,0,GO:0016052,carbohydrate catabolic process,M10,1,0
1,0,-2.3,0,GO:1904996,positive regulation of leukocyte adhesion to vascular endothelial cell,M10,1,0
1,0,-4.9,0,GO:0009595,detection of biotic stimulus,M10,1,0
1,0,-2.9,0,GO:0042063,gliogenesis,M10,1,0
1,0,-3.6,0,GO:0031652,positive regulation of heat generation,M10,1,0
1,0,-4.6,0,GO:1902532,negative regulation of intracellular signal transduction,M10,1,0
1,0,-6.6,0,GO:0032680,regulation of tumor necrosis factor production,M10,1,0
1,0,-8.6,0,GO:1903037,regulation of leukocyte cell-cell adhesion,M10,1,0
0,1,0,-3.3,GO:0001764,neuron migration,M01,1,0
1,0,-3.5,0,GO:0060586,multicellular organismal-level iron ion homeostasis,M10,1,0
1,0,-2.7,0,GO:1901739,regulation of myoblast fusion,M10,1,0
1,0,-3.6,0,WP5039,SARS CoV 2 innate immunity evasion and cell specific immune response,M10,1,0
1,0,-3,0,R-HSA-168179,Toll Like Receptor TLR1:TLR2 Cascade,M10,1,0
0,1,0,-3,M48,PID MET PATHWAY,M01,1,0
1,0,-2.7,0,GO:0048143,astrocyte activation,M10,1,0
1,0,-4.1,0,R-HSA-5603041,IRAK4 deficiency (TLR2/4),M10,1,0
1,0,-3,0,GO:0002862,negative regulation of inflammatory response to antigenic stimulus,M10,1,0
0,1,0,-2.3,GO:0060071,"Wnt signaling pathway, planar cell polarity pathway",M01,1,0
1,0,-7.8,0,WP5095,Overview of proinflammatory and profibrotic mediators,M10,1,0
1,0,-4.2,0,R-HSA-5602498,MyD88 deficiency (TLR2/4),M10,1,0
1,0,-2.1,0,R-HSA-9759476,Regulation of Homotypic Cell-Cell Adhesion,M10,1,0
0,1,0,-3.8,GO:0014850,response to muscle activity,M01,1,0
0,1,0,-2.9,GO:0030220,platelet formation,M01,1,0
1,0,-2.2,0,R-HSA-5620971,Pyroptosis,M10,1,0
1,0,-2.6,0,GO:0046626,regulation of insulin receptor signaling pathway,M10,1,0
1,0,-4.4,0,GO:0043122,regulation of canonical NF-kappaB signal transduction,M10,1,0
1,0,-5.2,0,GO:0007599,hemostasis,M10,1,0
0,1,0,-2.3,R-HSA-9006936,Signaling by TGFB family members,M01,1,0
1,0,-4.9,0,GO:0051384,response to glucocorticoid,M10,1,0
1,0,-3.1,0,GO:0034142,toll-like receptor 4 signaling pathway,M10,1,0
1,0,-2.8,0,GO:0051917,regulation of fibrinolysis,M10,1,0
1,0,-57,0,R-HSA-6798695,Neutrophil degranulation,M10,1,0
0,1,0,-2,GO:1990778,protein localization to cell periphery,M01,1,0
0,1,0,-2.8,GO:0042552,myelination,M01,1,0
1,0,-4.4,0,GO:1903318,negative regulation of protein maturation,M10,1,0
0,1,0,-2.3,GO:0046488,phosphatidylinositol metabolic process,M01,1,0
1,0,-2.4,0,GO:0071407,cellular response to organic cyclic compound,M10,1,0
1,0,-2.2,0,GO:0007613,memory,M10,1,0
1,0,-3,0,GO:0051044,positive regulation of membrane protein ectodomain proteolysis,M10,1,0
0,1,0,-2.4,GO:0008154,actin polymerization or depolymerization,M01,1,0
1,0,-5.3,0,GO:0032743,positive regulation of interleukin-2 production,M10,1,0
1,0,-3.4,0,GO:0071624,positive regulation of granulocyte chemotaxis,M10,1,0
1,0,-4.6,0,GO:0007596,blood coagulation,M10,1,0
1,0,-4.2,0,R-HSA-5260271,Diseases of Immune System,M10,1,0
1,0,-3,0,GO:0006026,aminoglycan catabolic process,M10,1,0
1,0,-3.7,0,GO:0050672,negative regulation of lymphocyte proliferation,M10,1,0
1,0,-3,0,GO:0099509,regulation of presynaptic cytosolic calcium ion concentration,M10,1,0
1,0,-4,0,GO:0055082,intracellular chemical homeostasis,M10,1,0
1,0,-2.1,0,R-HSA-114608,Platelet degranulation,M10,1,0
1,0,-2.1,0,R-HSA-163125,Post-translational modification: synthesis of GPI-anchored proteins,M10,1,0
1,0,-2.6,0,GO:0019370,leukotriene biosynthetic process,M10,1,0
0,1,0,-2.5,GO:0050807,regulation of synapse organization,M01,1,0
1,0,-2.7,0,GO:0016064,immunoglobulin mediated immune response,M10,1,0
0,1,0,-4.1,WP5289,Axon guidance,M01,1,0
1,0,-14,0,GO:0002429,immune response-activating cell surface receptor signaling pathway,M10,1,0
1,0,-2.5,0,WP167,Eicosanoid synthesis,M10,1,0
1,0,-7.5,0,GO:0034113,heterotypic cell-cell adhesion,M10,1,0
1,0,-3.2,0,GO:0032970,regulation of actin filament-based process,M10,1,0
0,1,0,-2.1,WP364,IL6 signaling,M01,1,0
1,0,-8,0,GO:0045785,positive regulation of cell adhesion,M10,1,0
1,0,-5.9,0,GO:0032642,regulation of chemokine production,M10,1,0
1,0,-5.4,0,GO:0032675,regulation of interleukin-6 production,M10,1,0
1,0,-2.5,0,GO:0051897,positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction,M10,1,0
1,0,-4.1,0,GO:0061760,antifungal innate immune response,M10,1,0
1,0,-6.2,0,WP5285,Immune infiltration in pancreatic cancer,M10,1,0
1,0,-16,0,R-HSA-373076,Class A/1 (Rhodopsin-like receptors),M10,1,0
1,0,-5.2,0,hsa05417,Lipid and atherosclerosis,M10,1,0
1,0,-11,0,hsa05150,Staphylococcus aureus infection,M10,1,0
1,0,-2.3,0,GO:0051873,killing by host of symbiont cells,M10,1,0
1,0,-5.8,0,GO:0042116,macrophage activation,M10,1,0
1,0,-2,0,GO:0048167,regulation of synaptic plasticity,M10,1,0
1,0,-17,0,GO:0002253,activation of immune response,M10,1,0
1,0,-5.4,0,GO:0050869,negative regulation of B cell activation,M10,1,0
1,0,-10,0,GO:0001818,negative regulation of cytokine production,M10,1,0
1,0,-9.3,0,WP3945,TYROBP causal network in microglia,M10,1,0
0,1,0,-2.7,GO:0008366,axon ensheathment,M01,1,0
1,0,-3.3,0,GO:0051048,negative regulation of secretion,M10,1,0
1,0,-7.5,0,R-HSA-9664424,Cell recruitment (pro-inflammatory response),M10,1,0
1,0,-4.4,0,GO:0010955,negative regulation of protein processing,M10,1,0
1,0,-4.2,0,GO:0010543,regulation of platelet activation,M10,1,0
1,0,-4.8,0,GO:0008360,regulation of cell shape,M10,1,0
0,1,0,-2.2,hsa04935,"Growth hormone synthesis, secretion and action",M01,1,0
0,1,0,-3.3,hsa04960,Aldosterone-regulated sodium reabsorption,M01,1,0
1,0,-2.7,0,WP3287,Overview of nanoparticle effects,M10,1,0
1,0,-3.3,0,GO:0070555,response to interleukin-1,M10,1,0
1,0,-2.3,0,M50,PID PTP1B PATHWAY,M10,1,0
1,0,-2.7,0,GO:0043086,negative regulation of catalytic activity,M10,1,0
1,0,-3.3,0,WP5148,Complement mediated inflammation of pulmonary alveolus in COVID 19 hypothetical pathway,M10,1,0
1,0,-2.6,0,hsa05142,Chagas disease,M10,1,0
1,0,-6.8,0,GO:0070098,chemokine-mediated signaling pathway,M10,1,0
0,1,0,-3.1,GO:0019079,viral genome replication,M01,1,0
1,0,-3.3,0,GO:0030212,hyaluronan metabolic process,M10,1,0
1,0,-3.4,0,GO:0071214,cellular response to abiotic stimulus,M10,1,0
1,0,-5.1,0,GO:0051924,regulation of calcium ion transport,M10,1,0
0,1,0,-2.3,GO:0070227,lymphocyte apoptotic process,M01,1,0
1,0,-8.2,0,GO:0043300,regulation of leukocyte degranulation,M10,1,0
1,0,-2.1,0,hsa04630,JAK-STAT signaling pathway,M10,1,0
0,1,0,-2.5,M207,PID RETINOIC ACID PATHWAY,M01,1,0
1,0,-2.6,0,GO:0031667,response to nutrient levels,M10,1,0
1,0,-4.2,0,GO:0031646,positive regulation of nervous system process,M10,1,0
1,0,-2.4,0,GO:0045776,negative regulation of blood pressure,M10,1,0
1,0,-17,0,GO:0002703,regulation of leukocyte mediated immunity,M10,1,0
0,1,0,-2.7,WP304,Kit receptor signaling,M01,1,0
1,0,-2.8,0,GO:0002827,positive regulation of T-helper 1 type immune response,M10,1,0
1,0,-3.9,0,GO:0002823,negative regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,M10,1,0
1,0,-3.1,0,M275,PID ALPHA SYNUCLEIN PATHWAY,M10,1,0
1,0,-5.3,0,GO:0045229,external encapsulating structure organization,M10,1,0
0,1,0,-2.4,GO:0050803,regulation of synapse structure or activity,M01,1,0
1,0,-2.8,0,GO:0043405,regulation of MAP kinase activity,M10,1,0
1,0,-3.3,0,WP382,MAPK signaling,M10,1,0
1,0,-2,0,GO:0051781,positive regulation of cell division,M10,1,0
1,0,-2.8,0,WP619,Type II interferon signaling,M10,1,0
0,1,0,-2.7,GO:1905063,regulation of vascular associated smooth muscle cell differentiation,M01,1,0
0,1,0,-3.9,GO:0009792,embryo development ending in birth or egg hatching,M01,1,0
1,0,-2.5,0,GO:1905952,regulation of lipid localization,M10,1,0
0,1,0,-2,GO:0009306,protein secretion,M01,1,0
1,0,-11,0,hsa05133,Pertussis,M10,1,0
1,0,-2.1,0,GO:0032703,negative regulation of interleukin-2 production,M10,1,0
1,0,-2.8,0,WP4808,Endochondral ossification with skeletal dysplasias,M10,1,0
0,1,0,-2,M175,PID ERBB2 ERBB3 PATHWAY,M01,1,0
1,0,-5.8,0,WP5353,Macrophage stimulating protein MSP signaling,M10,1,0
1,0,-6.5,0,WP3617,Photodynamic therapy induced NF kB survival signaling,M10,1,0
1,0,-2.5,0,GO:0055080,monoatomic cation homeostasis,M10,1,0
0,1,0,-2.2,GO:0051960,regulation of nervous system development,M01,1,0
1,0,-5.9,0,WP2882,Nuclear receptors meta pathway,M10,1,0
1,0,-2.4,0,GO:0006213,pyrimidine nucleoside metabolic process,M10,1,0
1,0,-3.7,0,WP4146,Macrophage markers,M10,1,0
1,0,-2.8,0,GO:0032963,collagen metabolic process,M10,1,0
1,0,-2.9,0,GO:0010574,regulation of vascular endothelial growth factor production,M10,1,0
